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Abstract
Multicellular organisms constantly encounter microbes, ranging from beneficial to pathogenic. In order to
mount appropriate immune responses that allow the host to clear pathogens while maintaining a balance with
nonpathogenic microbes, the innate immune system must discriminate between pathogens and commensals.
Through the recognition of virulence structures and activities, innate immune cells can distinguish pathogens
from commensals. One such virulence structure, the type III secretion system (T3SS), translocates effector
proteins into target cells in order to disrupt or modulate host cell signaling pathways and establish replicative
niches. Over 25 species of pathogenic gram-negative bacteria depend upon T3SSs to cause productive
infection. However, recognition of T3SS activity by cytosolic Pattern Recognition Receptors (PRRs) of the
Nucleotide-Binding Domain Leucine Rich Repeat (NLR) family, either through detection of translocated
products or membrane disruption, induces assembly of multiprotein complexes known as inflammasomes.
Yersinia pseudotuberculosis (Yptb) is an ideal model for inflammasome recognition of the T3SS as Yptb
expresses an archetypal T3SS and is a genetically tractable, natural rodent pathogen. Investigation of the
interaction between the inflammasomes and the T3SS could reveal important mechanistic and cell biological
information about the inflammasomes themselves as well as a potential target for treating T3SS expressing
bacteria. Although effectors of Yptb has been shown to actively inhibit inflammasome activation, until this
work very little was known about what inflammasome is actually activated by the T3SS, what activity of the
T3SS is recognized, and how Yersinia’s YopK protein inhibits inflammasome activation. Therefore, we
investigated the bacterial and host interactions required for inflammasome activation and the mechanism by
which YopK inhibits inflammasome activation. To dissect the contribution of the different consequences of
T3SSs, pore-formation and translocation, to inflammasome activation, we took advantage of variants of YopD
and LcrH that separate these functions. Our findings indicated that inflammasome activation required hyper-
translocation of YopB/D. Using macrophages deficient in caspase-1, caspase-11, or certain guanylate binding
proteins, we characterized the host pathways activated by hyper-translocation of YopD/B. Finally, using
mutations in YopK, we characterized how YopK prevents inflammasome activation. Overall, our findings help
define how bacterial virulence activities activate innate immune responses.
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Abstract 
Activation and Evasion of the Inflammasome by Yersinia 
Erin E. Zwack 
Igor E. Brodsky 
Multicellular organisms constantly encounter microbes, ranging from beneficial to pathogenic. In 
order to mount appropriate immune responses that allow the host to clear pathogens while 
maintaining a balance with nonpathogenic microbes, the innate immune system must 
discriminate between pathogens and commensals.  Through the recognition of virulence 
structures and activities, innate immune cells can distinguish pathogens from commensals. One 
such virulence structure, the type III secretion system (T3SS), translocates effector proteins into 
target cells in order to disrupt or modulate host cell signaling pathways and establish replicative 
niches. Over 25 species of pathogenic gram-negative bacteria depend upon T3SSs to cause 
productive infection. However, recognition of T3SS activity by cytosolic Pattern Recognition 
Receptors (PRRs) of the Nucleotide-Binding Domain Leucine Rich Repeat (NLR) family, either 
through detection of translocated products or membrane disruption, induces assembly of 
multiprotein complexes known as inflammasomes. Yersinia pseudotuberculosis (Yptb) is an ideal 
model for inflammasome recognition of the T3SS as Yptb expresses an archetypal T3SS and is a 
genetically tractable, natural rodent pathogen. Investigation of the interaction between the 
inflammasomes and the T3SS could reveal important mechanistic and cell biological information 
about the inflammasomes themselves as well as a potential target for treating T3SS expressing 
bacteria. Although effectors of Yptb has been shown to actively inhibit inflammasome activation, 
until this work very little was known about what inflammasome is actually activated by the T3SS, 
what activity of the T3SS is recognized, and how Yersinia’s YopK protein inhibits inflammasome 
activation. Therefore, we investigated the bacterial and host interactions required for 
inflammasome activation and the mechanism by which YopK inhibits inflammasome activation. 
To dissect the contribution of the different consequences of T3SSs, pore-formation and 
translocation, to inflammasome activation, we took advantage of variants of YopD and LcrH that 
separate these functions. Our findings indicated that inflammasome activation required hyper-
translocation of YopB/D. Using macrophages deficient in caspase-1, caspase-11, or certain 
guanylate binding proteins, we characterized the host pathways activated by hyper-translocation 
of YopD/B. Finally, using mutations in YopK, we characterized how YopK prevents inflammasome 
activation. Overall, our findings help define how bacterial virulence activities activate innate 
immune responses.   
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INTRODUCTION  
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A. Microbes and Pathogens 
 
Microbes constantly colonize the human body. The whole contingent of colonizing 
microbes comprises the microbiota. Humans depend on our microbiota for functions 
ranging from nutrient acquisition to immune function (Molloy et al., 2012; Sansonetti et 
al., 2011). In addition to the beneficial and neutral microbes that constantly colonize 
eukaryotic surfaces and tissues, humans encounter pathogenic microbes, which cause 
damage to the host upon infection. For an infection to be productive, the microbe needs 
to replicate inside the host and then spread to other hosts or environments where it can 
successfully multiply. The harm caused to the host as part of the pathogens life cycle 
distinguishes pathogens from other microbes.  Virulence structures and factors allow for 
the pathogen to set-up a productive infection, which will damage the host. Different 
virulence structures play important roles in varying aspects of infection. For example, 
modulation of host cell processes to prevent clearance or obtain nutrients can be driven 
by delivery of effectors into cells by specialized secretion systems (Coburn et al., 2007). 
Additionally appropriate adhesion of the pathogen to host surfaces to both prevent 
clearance and allow for dissemination can be modulated by various virulence structures 
such as pili (Gerlach and Hensel, 2007). Virulence factors such as toxins can also play 
multiple roles such as allowing for nutrient acquisition, killing cell types that could allow 
for clearance of the pathogen, and promoting environments that allow for increased 
transmission to new hosts (Chaussee et al., 1997; do Vale et al., 2016; Spaan et al., 
2015). The immune response to pathogens often requires robust innate and adaptive 
responses that try to eradicate the pathogen even at the expense of tissue damage. This 
is in contrast to the responses to the microbiota, which maintain the balance between 
host and microbe with limited and tightly controlled inflammation (Sansonetti, 2011). 
Inappropriate immune responses to commensals often lead to chronic inflammatory 
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diseases (Belkaid and Hand, 2014). Because of the disparate natures of the responses 
required to manage pathogens and commensals, a critical function of the immune system 
is distinguishing pathogens from commensals.  
B. Innate immune recognition of pathogens 
Once pathogens breach epithelial barriers, innate immune cells including neutrophils, 
macrophages, and dendritic cells often are the first cells to encounter pathogens. The 
signals produced by innate cells play a key role in restricting pathogen replication as well 
as instructing the subsequent immune responses. The immune cells recognize both 
virulence structures and activities of pathogens. How an innate immune cell recognizes a 
microbe determines the type and robustness of the response. Surface associated pattern 
recognition receptors such as the Toll-like receptors (TLRs) recognize conserved 
molecular patterns such as bacterial lipopolysaccharide (LPS), flagellin, and 
peptidoglycan (Chow et al., 1999; Hayashi et al., 2001; Janeway and Medzhitov, 2002; 
Poltorak et al., 1998; Schwandner et al. 1999). These molecules are conserved among 
nonpathogenic and pathogenic bacteria. The response downstream of recognition 
consists mainly of a transcriptional response with the up-regulation of many 
proinflammatory cytokines. Some of these cytokines are secreted to trigger similar 
transcriptional changes in neighboring cells while other cytokines are produced in a pro-
form that require post-translational modification (Vance et al., 2009). Additionally, post-
translational modifications can be required to induce activity of certain enzymes. 
Detection of a second signal that is specific to pathogens normally controls these post-
translational modifications. Pathogen specific secondary signals range from detection of 
conserved microbial products in the cytosol to inhibition of normal cell processes such as 
transcription and translation to formation of pores in membranes by toxins or other 
microbial proteins (Vance et al., 2009). Different classes of pathogen-associated signals 
can engage different signaling pathways resulting in divergent outcomes. For example, 
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pathogen-induced blockade of transcription or translation after initial priming by surface 
receptor signaling often leads to apoptotic cell death (Monack et al., 1997; Palmer et al., 
1998; Gil and Esteban, 2000), whereas sensing pore-forming toxins or introduction of 
bacterial products such as flagellin into the cytosol results in a pro-inflammatory form of 
cell death termed pyroptosis (Bergsbaken et al., 2009; Miao et al., 2006; Miao et al., 
2010a; Craven et al., 2009). Pyroptosis involves the activation of a multiprotein complex 
termed the inflammasome (Martinon et al., 2002).  
C. The canonical inflammasomes 
The inflammasomes are multi-protein complexes that typically consist of a nucleotide 
binding domain leucine rich repeat protein (NLR), the apoptosis-associated speck-like 
protein containing a carboxy-terminal caspase recruitment domain (ASC), and the 
cysteine protease caspase-1 (Fig. 1-1; Martinon et al., 2002). Recent studies using 
super-resolution microscopy revealed that the inflammasome complex forms a spiral tube 
with the NLRs on the outside and caspase-1 on the inside of the structure (Man et al., 
2014). Upon oligomerization in the complex, caspase-1 undergoes autocleavage into the 
active p10 and p20 subunits from its 45 kDa proform (Martinon et al., 2002).  
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Figure 1-1: Model of Canonical Inflammasome activation. Three inflammasomes (NLRP3, 
NLRC4, and AIM2) that demonstrate the paradigm of canonical inflammasomes are depicted. 
The NLRP3 inflammasome (Left) uses the NLR protein NLRP3, which contains a leucine rich 
repeat (LRR) domain, a nucleotide binding domain (NBD) and a pyrin domain (PYD). Upon 
activation by one of its many stimuli, NLRP3 recruits the adapter protein ASC, which contains 
both a PYD and caspase activation and recruitment domain (CARD). ASC allows for the cysteine 
protease caspase-1 to be recruited. The AIM2 inflammasome (middle) requires the protein AIM2, 
which has a Hematopoietic interferon-inducible nuclear domain (HIN) and a PYD, to sense 
cytosolic DNA. Upon activation, recruitment of ASC and caspase-1 occurs. The NLRC4 
inflammasome (right) is named for the use of the protein NLRC4, which consists of an LRR, NBD, 
and CARD. As NLRC4 contains a CARD, it can directly recruit caspase-1. Alternatively, NLRC4 
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can interact with caspase-1 through ASC. Downstream of formation of the ASC-containing 
inflammasome, IL-1α, IL-1β, and IL-18 secretion occurs along with death. Direct recruitment of 
caspase-1 by NLRC4 leads only to death. 
 
 
The activation of capase-1 in the inflammasome complex leads to the processing of IL-1 
family cytokines IL-1β and IL-18 (Martinon et al., 2002). Caspase-1 activation is 
additionally required for secretion of IL-1β and IL-18 as well as IL-1α, which is thought to 
be active in both its pro and processed form and does not use caspase-1 for processing 
(Mosley et al., 1987). Processing and secretion of these cytokines require oligomerization 
of the complex using the adaptor protein ASC.  In addition to the processing and 
secretion of IL-1 family cytokines, caspase-1 activation leads to a type of death called 
pyroptosis (Bergsbaken et al., 2009). Caspase-1 mediated death does not require this 
oligomerization. NLRC4, which can bind directly to caspase-1 via its caspase-1 activation 
and recruitment domain (CARD), has been shown to allow for cell death in the absence 
of ASC foci (Fig. 1-1; Case et al., 2009; Case and Roy, 2011). Recently, this death has 
been shown to require cleavage of GasderminD (encoded by Gsdmd) by caspase-1 (Shi 
et al., 2015). Cleavage frees the N-terminus of GSDMD, which is sufficient to cause 
pyroptotic-like death although the precise mechanism is unknown (Shi J et al., 2015; 
Kayagaki et al., 2015).  
 
The various stimuli that trigger inflammasome activation require different NLRs. Direct 
binding of any stimuli to an NLR has yet to be demonstrated. NLRC4 was initially thought 
to bind directly to its stimuli of flagellin, but it has since been shown that neuronal 
apoptosis inhibitory protein (NAIP) 5 binds flagellin and then activates NLRC4 (Lightfield 
et al., 2008). NLRC4 also works in conjunction with NAIP2 and NAIP1 to detect the type 
three secretion system (T3SS) inner rod and needle proteins, respectively (Miao et al. 
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2010b; Yang et al., 2013). The NLRC4 stimuli are structurally and conceptually related as 
they make up the rod portions of the evolutionarily related flagellar apparatus and type 
three secretion system. NLRP3 recognizes a wide range of stimuli including pore-forming 
toxins, uric acid and silica crystals, lysosomal disruption, and extracellular adenosine 
triphosphate (ATP) with LPS priming (Fig. 1-1; Craven et al., 2009; Hornung et al., 2008; 
Mariathasan et al., 2006; Martinon et al. 2006). How all of these various NLRP3 stimuli 
lead to inflammasome activation is unknown although potassium efflux is required for 
NLRP3 inflammasome activation by all described stimuli to date (Munoz-Planillo et al., 
2013). In addition to NLRs, absent in melanoma 2 (AIM2), which contains a 
hematopoietic interferon-inducible nuclear domain (HIN) and a pyrin domain (PYD), 
activates the inflammasome downstream of recognition of double stranded cytosolic DNA 
(Fig. 1-1; Fernandes-Alnemri et al., 2009; Hornung et al., 2009). If multiple stimuli are 
acting upon the cell, all activated NLRs go to the same structure generating a single 
caspase-1 puncta (Man et al., 2014). While typically caspase-1 is required for all aspects 
of pyroptosis, caspase-11 can lead to caspase-1-independent cell death and IL-1α 
secretion with caspase-1-dependent IL-1β and IL-18 secretion under certain 
circumstances (Kayagaki et al., 2011). 
D. The non-canonical inflammasome 
In 1998 before the inflammasome was defined, Wang S et al. determined that caspase-
11 was required for IL-1α and IL-1β secretion after injection of LPS into mice. In 2011, it 
was determined that Casp1-/- mice, which were supposed to be missing only caspase-1, 
produced a nonfunctional, truncated form of caspase-11. The caspase-1 deletion was 
initially generated on a 129 mouse background. In 129 mice, caspase-11 contains a 
mutation that results in a non-functional truncated caspase-11. Caspase-1 and caspase-
11 are too close on the chromosome to allow for segregation. Therefore, the 
nonfunctional caspase-11 could not be swapped with the functional caspase-11 of 
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C57Bl/6 mice (Kayagaki et al., 2011). Until this point, all experiments to determine a role 
for the inflammasome used the Casp1-/-Casp11-/- mice. Generation of Casp1 and Casp11 
single knockout mice determined that while caspase-11 was dispensable for certain 
stimuli such as extracellular ATP with priming and monosodium urate crystals, caspase-
11 and not caspase-1 was required for cell death and IL-1α release in response to 
infection with nonpathogenic gram-negative bacteria (Kayagaki et al., 2011). 
Interestingly, both caspase-1 and caspase-11 were required for IL-
1β processing and secretion. This combination of caspase-11-dependent, caspase-1-
independent cell death and IL-1α secretion, and caspase-1/11-dependent IL-1β secretion 
was termed the non-canonical inflammasome response (Fig. 1-2, Kayagaki et al., 2011). 
The actual trigger from infection with gram-negative nonpathogenic bacteria is the 
release of hexa-acylated or penta-acylated lipid A of LPS into the cytosol (Hagar et al., 
2013; Kayagaki et al., 2013; Shi et al., 2014). Hexa-acylated lipid A was found to bind 
directly to caspase-11 in the cytosol. Intracellular LPS is currently the only known 
activator of the non-canonical inflammasome (Shi et al., 2014).  
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Figure 1-2: Non-canonical inflammasome activation. Intracellular hexa-acylated LPS 
activates caspase-11 leading directly to cell death and IL-1α secretion. Caspase-11 
activation also leads to activation of the canonical NLRP3 inflammasome, which allows for 
the processing and secretion of IL-1β and IL-18 as well as cell death and IL-1α secretion. 
 
Interestingly, a subset of interferon inducible GTPases called guanylate binding proteins 
(Gbps) was found to be important for the activation of the non-canonical inflammasome 
(Meunier et al., 2014; Pilla et al., 2014). Gbps were initially characterized to aid in 
protection against vacuolar pathogens such as intracellular parasites and bacteria. After 
being recruited to the vacuole, Gbps recruit nitric oxide synthase machinery and 
autophagy machinery to control these pathogens (MacMicking, 2012). During non-
canonical inflammasome activation, Gbps play a role both when lipid A is directly 
transfected into the cytosol as well as during infection with gram-negative bacteria (Pilla 
et al., 2014; Meunier et al., 2014). In the case of gram-negative bacterial infection, Gbps 
are thought to lyse the lysosome to release the lipid A, as one group has shown to be the 
case (Meunier et al., 2014). The role of Gbps in the cytosol is less well defined. The 
Coers group showed that transfected LPS from Legionella pneumophila, Escherichia coli, 
and Salmonella Minnesota had significantly lower non-canonical inflammasome 
activation in the absence of the Gbps from chromosome 3 (Pilla et al., 2014). 
Additionally, Chlamydia muridarum, which successfully excludes Gbps from its vacuole, 
activates both the non-canonical inflammasome and canonical inflammasome. 
Inflammasome activation by Chlamydia muridarum is dependent on the Gbps on 
chromosome 3 (Finethy et al., 2015). In both of these models, the individual contributions 
of the Gbps have yet to be determined. It has been suggested that Gbps may act as a 
platform to facilitate formation of the non-canonical inflammasome (Pilla et al., 2014). 
This hypothesis is based on Gbps being shown to both bind NLRP3 and be required for 
higher levels of NLRP3-ASC complex oligomerization (Shenoy et al., 2012). 
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E. The Role of inflammasome activation in immune response 
Both inflammasome-dependent cell death and cytokine release play important roles in 
the immune response. Triggering death of infected cells destroys the replicative niche of 
obligate intracellular pathogens and exposes intracellular pathogens to extracellular 
defenses such as complement, antibody, and neutrophils (Chow et al., 2016). It has also 
been speculated that extracellular bacteria that attach to cells are cleared when 
macrophages clear the now dead cell to which they are attached (Bergman et al., 2009). 
In addition to causing immediate harm to the pathogen, the nature of the death allows for 
the release of damage-associated molecular patterns (DAMPs) such as HMGB1 and 
ATP. These DAMPs can then signal through pattern recognition receptors (PRRs) and 
other receptors on surrounding cells to stimulate cytokine production and recruitment of 
immune cells (Bergsbaken et al., 2009). 
 
In addition to signaling by DAMPs, the inflammasome actively secretes the pro-
inflammatory cytokines IL-1α, IL-1β, and IL-18. IL-1α and IL-1β signal through the same 
receptor IL-1R (Dower et al., 1986) while IL-18 signals through the IL-18R (Debets et al., 
2000). Signaling by IL-1α, IL-1β, and potentially IL-18 leads to upregulation of the 
chemokine CXCL1, which triggers neutrophil recruitment (Lee et al., 2015; He et al., 
2008). Additionally, IL-1β and IL-18 lead to activation of macrophages and dendritic cells 
(DCs) by stimulating noncognate production of granulocyte-macrophage colony-
stimulating factor (GM-CSF) and interferon gamma (IFNγ) respectively by T-cells (Lukens 
et al., 2012; Kupz et al., 2012). The enhancement of innate responses can play a critical 
role in bacterial clearance. 
 
 Signaling by IL-1α and IL-1β also play important roles in generating adaptive responses 
both directly and indirectly. IL-1α and IL-1β signaling act directly on T-cells to differentiate 
them into Th17 cells in an antigen-specific manner (Sutton et al., 2006). More frequently, 
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we observe indirect effects of IL-1α and IL-1β on T-cells through interactions with DCs 
that have experienced IL-1R signaling. In West Nile Virus infection IL-1R signaling in 
subsets of DCs was critical for effector T-cell reactivation in the central nervous system 
(Durrant et al., 2013). Activation of DCs by IL-1R signaling was required for pathologic 
CD4 T-cell response in autoimmune myocarditis (Eriksson et al., 2003). Additionally, IL-
1R signaling was required for migration of DC cells to the draining lymph node during flu 
infection. Failure of IL-1R-/- DCs to migrate to the draining lymph node resulted in 
decreased CD8 T-cell function (Pang et al., 2013). The complex, multi-armed response 
generated by the inflammasome combined with the wide range of stimuli recognized 
makes the inflammasome a guardian against many types of pathogenic threats. In my 
thesis work, I focused on understanding how the inflammasome recognizes a conserved 
virulence structure that allows for bacterial pathogens to subvert the host in unique ways 
to promote infection. 
F. The Type Three Secretion System of gram-negative bacteria 
There are various mechanisms by which bacteria secrete protein products from within the 
bacteria to extracellular spaces. These systems are termed type 1 – type VII secretion 
depending on their structures and evolutionary relationships (Green and Mecsas, 2016). 
The type III secretion system (T3SS) is found exclusively in gram-negatives and is 
utilized to translocate bacterial proteins into host cells. The name type three secretion 
first appeared in a review describing type 1 and type 2 secretion in gram-negative 
bacteria (Salmond and Reeves, 1993). The secretion of Yersinia outer proteins (Yops) by 
Yersinia enterocolitica did not match either pathway. Additionally, proteins found in 
Pseudomonas solanacearum were homologous to Yersinia proteins required for Yop 
secretion (Salmond and Reeves, 1993). Thus, it was posited that a novel pathway 
existed for secretion. Many of these secreted proteins such as YopE of Yersinia and 
Exoenzyme S (ExoS) of Pseudomonas were found to only affect cells when inside the 
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host cell (Rosqvist et al., 1990; Frithz-Lindsten et al., 1997). The proteins YopD and 
YopB of Yersinia were found to be necessary for delivery of YopE into the host cell 
(Rosqvist et al., 1995; Sory and Cornelis, 1994).  Further characterization of T3SSs 
determined a general structure (Fig. 1-3), which includes two membrane spanning rings. 
A cytosolic ATPase provides the power for pumping out effectors (Diepold et al., 2012). 
Connected to the cytosolic components is the inner membrane export apparatus, which is 
inside the membrane and supramembrane ring (MS ring). The MS ring spans the inner 
membrane and connects with the outer membrane secretin ring in the periplasm (Diepold 
et al., 2012). Lining the channel inside the bacterium is the inner rod. The needle follows 
the rod and spans the space between the bacterium and host cell. At the tip of the needle 
is the translocon, which interacts with the host cell membrane and allows for entry of 
effectors into the cell (Diepold et al., 2012). The structure of the T3SS described above is 
highly similar to the structure of the bacterial flagellar apparatus. Phylogenetic studies 
determined that they share a common ancestor (Gophna et al., 2003). The similarity in 
structure allows for accidental translocation of flagellin monomers by the T3SS, which 
leads to potent activation of the NLRC4 inflammasome (Badea et al., 2009; Franchi et al., 
2006, Lightfield et al., 2008; Miao et al., 2006; Miao et al., 2008). Even though accidental 
translocation of flagellin allows for immune detection of certain T3SS expressing bacteria, 
the T3SS is still essential to the survival or virulence of these bacteria (Galan and Curtiss, 
1989; Galle et al., 2012).  
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Figure 1-3: Schematic of T3SS. IM - inner membrane, PP - periplasm, OM – outer 
membrane, HM - host membrane, MS - membrane and supramembrane.   
 
In general, deletion or inhibition of the T3SS leads to attenuation of infection by the 
bacteria (Bailey et al. 2007; Coburn et al., 2007; Gemski et al., 1980a, Gemski et al., 
1980b; Galan and Curtiss, 1989; Shea et al., 1996). Small molecule inhibitors have been 
found that can inhibit translocation of effectors (Muschiol et al., 2006; Harmon et al., 
2010). Many of these small molecule inhibitors affect translocation in multiple species. 
For example, an inhibitor originally identified to inhibit translocation by Yersinia 
pseudotuberculosis was also capable of inhibiting translocation in Chlamydia trachomatis 
and Chlamydia pneumoniae (Muschiol et al., 2006; Bailey et al., 2007). With increasing 
incidences of multi-drug resistant infections, new approaches to combating multiple 
groups of bacteria are becoming essential. 
 
Over 25 species of gram-negative bacteria express T3SSs including Chlamydia 
trachomatis, Pseudomonas aeruginosa, Salmonella enterica, Shigella flexneri, and 
Yersinia pestis. T3SS expressing bacteria infect a variety of hosts including plants, 
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insects, and mammals. Some are obligate intracellular bacteria while others are 
facultative intracellular bacteria and extracellular bacteria. The diverse niches that they 
occupy require different types of effectors to establish productive infection. However, the 
general structure of the T3SS as observed by electron microscopy remains well 
conserved among the different species (Cornelis, 2006). Such a well-conserved, 
essential virulence structure would make an excellent target for the various 
inflammasomes. Here we investigate the archetypal T3SS of Yersinia pseudotuberculosis 
to determine how the virulence activities of the T3SS such as pore-formation and 
translocation may be recognized by the inflammasomes. 
G. Human pathogenic Yersinia 
Yersinia species are gram-negative coccobacillus bacteria of the family 
Enterobacteriaceae. The genus Yersinia consists of 18 different species to date. Only 
three species of Yersinia are pathogenic to mammals including humans: Yersinia pestis 
(Yp), Yersinia pseudotuberculosis (Yptb), and Yersinia enterocolitica (Ye) (McNally et al., 
2016). Yersinia pestis, the most well known species of Yersinia, was identified as the 
causative agent of plague in 1894 (Rosenberg, 1968).  Transmission typically occurs 
either through the bite of an infected flea or the inhalation of Yp containing droplets from 
an individual infected with the pneumonic form of plague (Wren, 2003). While often 
thought of as exclusively a scourge of the past, plague is still around today. The prairie 
dog population of the Western United States provides a reservoir for Yp. The appearance 
of multi-drug resistant cases and its potential as a bioterrorism agent continue to draw 
interest to understanding Yersinia pestis. Inside the human host, Yp has a preference for 
leukocytes (Balada-Llasat and Mecsas, 2006; Maldonado-Arocho et al., 2013; Marketon 
et al., 2005).  During the bubonic form of the plague, bacteria traffics and grows in the 
lymph node resulting in inflammation and swelling of the lymph node.  Yp infection can 
also spread to the lungs (pneumonic plague) or systemically (septicemic plague) (Wren, 
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2003). Yp directly evolved from Yptb through a combination of gene acquisition and gene 
loss that allowed for transmission by fleas, a change in virulence, and restriction of 
lifestyle (Achtman et al., 1999; Chain et al., 2004; Hinnebusch et al., 2002; Zimbler et al., 
2015)  
 
While Yp is a vector-borne disease that often goes systemic, both Yptb (its direct 
ancestor) and Ye are transmitted through the oral-fecal route (Wren, 2003).  They share 
the same tropism for lymph nodes and leukocytes as Yp (Durand 2010, Koberle 2009). 
However, the diseases caused by these infection are usually self-limiting gastroenteritis 
and do not often go systemic in immunocompetent individuals. Ye is the most common 
cause of food-borne Yersinia infection (FDA, 2012). Although the route of transmission 
and actual disease caused by the three Yersinia species are distinct, the ability to infect 
mammals is conferred by a conserved 70 kb virulence plasmid that encodes a type III 
secretion system (T3SS) and associated effectors (Gemski et al., 1980a, Gemski et al., 
1980b; Portnoy et al., 1981, Cornelis and Wolf-Watz, 1997). Thus, we employ the less 
virulent Yersinia pseudotuberculosis to study the T3SS. Yersinia pseudotuberculosis is 
an ideal model system as it is a natural pathogen of rodents and provides a tractable 
host and bacterial genetic model to study natural systemic Yersinia infection.   
H. Yersinia type three secretion system and effectors 
As mentioned above, the Yersinia T3SS is an archetypal T3SS that was used to 
determine much of the structure and function of T3SSs in general (Cornelis and Wolf-
Watz, 1997). The T3SS allows for effectors to be translocated from the bacteria into the 
host cell (Cornelis and Wolf-Watz, 1997).  The translocon of Yersinia is comprised of the 
pore proteins YopB and YopD as well as the tip platform protein LcrV (Diepold et al., 
2012). In general, Yersinia pseudotuberculosis encodes six to seven effectors depending 
on strain: YopE, YopH, YopJ, YopK, YopM, YopO/YpkA, and YopT. The different 
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effectors influence host cell processes and structures in various ways that support 
Yersinia survival (Viboud and Bliska, 2005; Bliska et al., 2013). YopJ, an acetylase, 
inhibits NFκB and MAPK (Mukherjee et al., 2006; Palmer et al., 1998). In the absence of 
priming, YopJ activates a caspase-8-dependent apoptosis and inflammasome-
independent caspase-1 processing (Monack et al., 1997). When cells are primed prior to 
infection, this YopJ death pathway is circumvented, and YopJ in the absence of YopM 
seems to play a role in the inhibition of caspase-1 (Schoberle et al., 2016). 
 
In addition to working by themselves, several effectors may work in concert to affect the 
same host process. For example the effectors YopE, YopH, YopO, and YopT all target 
various cellular components that are important for phagocytosis (Rosqvist et al., 1990; 
Andersson et al., 1996; and Grosdent et al., 2002). While it has been shown that Yersinia 
can survive and replicate at some level in both macrophages and neutrophils 
(Cavanaugh and Randall, 1959, Pujol et al., 2003, Spinner et al., 2014), its preferred 
lifestyle seems to be extracellular. Through injection of this cohort of effectors, Yersinia 
both increases the likelihood that it will remain extracellular and decreases the ability of 
neutrophils to respond to Yersinia (Songsungthong et al., 2010, Rolan et al., 2013). The 
subversion of host defense such as neutrophil oxidative burst and phagocytosis seem to 
be a common theme among Yersinia’s effectors and most likely provides the ability to 
productively infect mammalian hosts. Interestingly, the same mechanism that allows for 
Yptb to infect mammals leaves Yersinia vulnerable to cytosolic immune pathways that 
otherwise would not have encountered Yersinia.  
I. The role of inflammasome activation in Yersinia infection 
As mentioned above YopJ can trigger caspase-1 activation through a caspase-8-
dependent pathway (Philip et al., 2014; Weng et al., 2014).  However, when 
macrophages are primed with TLR ligands before infection with wild-type Yersinia in vitro, 
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death of macrophages becomes caspase-1-dependent apoptosis-independent 
(Bergsbaken and Cookson, 2007). Intriguingly, the deletion of all known effectors 
severely attenuates Yersinia infection in C57BL/6 (B6) mice. This attenuation is relieved 
in caspase-1/11 deficient mice (Brodsky et al., 2010). As PrgJ (T3SS inner rod) and PrgI 
(T3SS needle subunit) of Salmonella activate the NLRC4 inflammasome (Miao et al., 
2010b; Yang et al., 2013), it seemed plausible that Yersinia inner rod (YscI) and needle 
(YscF) proteins caused the inflammasome activation.  Although there is some NLRC4-
dependent inflammasome activation during in vitro infection with effectorless Yersinia, the 
majority of caspase-1 processing is dependent on NLRP3 (Brodsky et al., 2010). 
Additionally at the time these experiments were performed, it was not known that the 
caspase-1-deficient mice were actually Casp1-/-Casp11-/- mice. Therefore, it was unclear 
whether the NLRP3-dependent caspase-1 processing was through the canonical or non-
canonical pathway. As both pathogens and commensals shed LPS and other molecules 
that stimulate TLR signaling, innate immune cells in vivo can have up-regulated pro-IL-
1β and other inflammasome associated proteins. Therefore, wild-type Yersinia should 
activate the inflammasome in vivo and would be susceptible to caspase-1/11-dependent 
clearance unless other effectors were capable of inhibiting inflammasome activation.  
J. Evasion of the inflammasome by Yersinia 
With the ability of the inflammasome to effectively control Yersinia, it is not surprising that 
Yersinia has multiple effectors that inhibit activation of the inflammasome. Interestingly, 
neither YopM or YopK, the two effectors that have been demonstrated to inhibit the 
inflammasome, employ enzymatic activities for this function. YopM’s mechanism of 
inflammasome inhibition is better defined than YopK’s. Evdokimov and colleagues initially 
crystalized YopM and determined that it contained leucine rich repeats (LRR) with very 
little additional secondary structure (2001). LRR domains typically are involved in protein-
protein interactions and binding. In the case of Yersinia pseudotuberculosis YPIII strain, a 
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capase-1 cleavage motif consisting of Tyrosine-Leucine-Threonine-Aspartic Acid  (YLTD) 
in the LRR domain was shown to allow YopM to directly bind to caspase-1 (LaRock and 
Cookson, 2012). The ability of YopM to bind caspase-1 was required to inhibit activation 
in this strain. Different strains of Yersinia pseudotuberculosis and Yersinia pestis express 
different isoforms of YopM (Boland et al., 1998). Interestingly while these isoforms also 
inhibit caspase-1 activation, they do not require binding to caspase-1 (Chung et al., 
2014). In the case of Yptb strain 32777, YopM is unable to bind caspase-1. Yp strain 
Kim5 has the same YLTD motif as Yptb YPIII; however, the aspartic acid residue and 
caspase-1 binding were not required for caspase-1 inhibition. Instead, the scaffolding 
protein IQGAP1, which interacts with YopM’s LRR, was required for caspase-1 inhibition 
(Chung et al., 2014). Interestingly, deletion of the c-terminus of YopM also abrogated the 
ability of YopM to inhibit caspase-1 activation (Chung et al., 2014). It has previously been 
shown that the c-terminus of YopM interacts with the kinase ribosomal S6 protein kinase 
1 (RSK1) (McPhee et al., 2010) and that the interaction with YopM increases the activity 
of RSK1 (McDonald et al., 2003). Whether this activation of RSK1 or some other protein 
interaction with the c-terminus of YopM is responsible for caspase-1 inhibition is still 
unknown. Additionally, it had been questioned whether YopM cooperated with any other 
effectors to inhibit inflammasome activation. 
 
To test whether YopM coordinated with other effectors, the ability of Yersinia to activate 
the inflammasome in primed macrophages was tested with strains that lacked both YopM 
and another effector (Schoberle et al., 2016). While single deletion of YopJ has no 
detectable effect on inflammasome activation in primed macrophages, deletion of YopJ 
and YopM together allows for greater inflammasome activation than YopM deletion alone 
(Schoberle et al., 2016). In unprimed macrophages, the effect of YopJ on the magnitude 
of inflammasome output in response to infection with Yersinia lacking YopM seems to be 
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a consequence of the suppression of pro-IL-1β and pro-IL-18 expression (Ratner et al., 
2016). However, in primed macrophages the effect of YopJ working in concert with YopM 
to inhibit the inflammasome seems to be independent of YopJ’s suppression of pro-IL-1β 
and pro-IL-18 expression (Schoberle et al., 2016). How YopJ and YopM are working 
together is still undefined. While YopM plays an important role in the inhibition of the 
inflammasome, the effector YopK has also been shown to be important for inhibition of 
the inflammasome by Yersinia.        
 
YopK was the first Yersinia effector described to inhibit inflammasome activation 
(Brodsky et al., 2010) and has long been demonstrated to be important for virulence. 
Although YopK performs important functions during Yersinia infection, no sequence 
homolog exists.  YopK knockouts were shown to cause attenuated infection in Balb/c 
mice (Straley and Cibull, 1989; Holmstrom et al., 1995), C57BL/6 mice (Brodsky et al., 
2010) and rabbits (Najdenski et al., 2003). While the mechanism for YopK inhibition of 
the inflammasome remains unknown, YopK was found to interact in several ways with 
Yersinia’s Type Three Secretion System, which is required for inflammasome activation. 
Initially, YopK was determined to negatively regulate translocation of other effectors and 
affect the lytic ability of the translocon pore potentially by decreasing pore size 
(Holmstrom et al., 1997). Originally, YopK was not thought to be translocated as it could 
not be visualized inside cells by confocal microscopy (Holmstrom et al., 1997). This result 
could be an effect of YopK being translocated at low levels or the epitope(s) recognized 
being obscured as more recent data employing GSK-tagged YopK and the YopK-β-
lactamase fusion system detected translocation of YopK into host cells (Brodsky et al., 
2010; Thorslund et al., 2011). It was then determined that to regulate translocation rate 
YopK acts inside the host cell (Dewoody et al., 2011). Furthermore, translocated YopK 
interacts with both YopD and YopB (Brodsky et al., 2010; Thorslund et al., 2011) as well 
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as host proteins (Thorslund et al., 2011). Initially Thorslund suggested interaction with the 
host protein RACK1 was important for YopK regulation of translocation; however, 
subsequent data suggest that while RACK1 interacts with YopK, this interaction may not 
be responsible for regulation of translocation (Dewoody et al., 2013). 
 
Determining how YopK inhibits the inflammasome can provide insights into potential 
functional homologs in other T3SS expressing bacteria. Additionally, understanding how 
YopK inhibits the inflammasome during Yersinia infection reveals potential targets for 
clinical intervention to reactivate an effective, natural pathway for Yersinia clearance.  
 
K. Dissertation Aims 
Over 25 species of pathogenic gram-negative bacteria depend upon the T3SS to cause 
productive infection. Their T3SSs appear structurally similar by electron microscopy and 
chemical inhibitors can effectively target T3SS from different families (Cornelis, 2006; 
Harmon et al., 2010; Muschiol et al., 2006) Outside of NLRC4 recognition of flagellin, the 
T3SS inner rod of Salmonella, and the T3SS needle subunit of Salmonella, not much is 
known about how recognition can occur and if pathogen subversion of the inflammasome 
is necessary for infection. Previous studies have implicated NLRC4-independent 
inflammasome activation in the recognition of T3SS expressing Yersinia (Brodsky et al., 
2010); potentially other T3SS expressing gram-negative bacteria can trigger similar 
responses. Yersinia pseudotuberculosis is an ideal model for inflammasome recognition 
of the T3SS as Yptb expresses an archetypal T3SS and provides a genetically tractable, 
natural rodent pathogen. Investigation into the interaction between the inflammasomes 
and the T3SS could reveal important mechanistic and cell biological information about 
the inflammasomes themselves as well as a potential target for treating T3SS expressing 
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bacteria. Although Yersinia pseudotuberculosis has been shown to actively inhibit 
inflammasome activation and NLRC4-independent inflammasomes recognize the T3SS 
(Brodsky et al., 2010), until this work very little was known about what inflammasome is 
actually activated by the T3SS, what activity of the T3SS is recognized, and how 
Yersinia’s YopK protein inhibits inflammasome activation. Therefore, the aims of the work 
presented in this dissertation are as follows:  
1) To determine the essential activities of the Yersinia T3SS that trigger inflammasome 
activation. 
 
Previous studies have shown that the T3SS of Yersinia activates the inflammasome in 
the absence of all of its known effectors. However, these mutants only lacked the six 
known effectors and still formed functional T3SSs. The recognition of the T3SS could 
potentially occur by either detection of the translocon pore or detection of a translocated 
molecule that is not one of the six known effectors. In Chapter 3, we used in-frame 
deletion mutations in the pore protein YopD to separate pore-formation from translocation 
in order to determine if pore-formation was sufficient to activate the inflammasome. We 
found that inflammasome activation by the T3SS required translocation. We further 
identified hyper-translocation of the translocon pore proteins YopD and YopB to be 
required for this activation. Delivery of membrane active proteins into the cytosol of host 
cells is not limited to T3SS expressing bacteria. Further understanding of how YopD and 
YopB activate the inflammasome may add insight into how other pathogens should or 
could be detected and cleared.   
 
2) To determine the role of the non-canonical inflammasome in recognition of the T3SS. 
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Previous studies identified a role for inflammasomes in the recognition of Yersinia 
expressing a T3SS. However, these studies were done using mice or bone-marrow-
derived macrophages (BMDMs) that functionally lacked both caspase-1 and caspase-11. 
As NLRC4 plays virtually no role in recognizing the Yersinia T3SS, we wished to 
determine whether the non-canonical or canonical inflammasomes recognize the T3SS. 
In chapter 4, we infected single Casp11-/- or Casp1-/- BMDMs to determine the 
contribution of the non-canonical inflammasome to recognition of the T3SS. Our findings 
indicate that the non-canonical inflammasome plays the dominant role in T3SS 
recognition, but there is a canonical inflammasome component. 
 
3) To dissect the molecular mechanisms that lead to inflammasome activation 
downstream of the initial trigger. 
 
The inflammasomes recognize a wide range of fairly divergent stimuli. By determining a 
molecular mechanism for activation of the inflammasomes downstream of the T3SS, we 
can potentially gain insights on how the inflammasome is activated in response to similar 
stimuli from other pathogen systems. In Chapter 4, we demonstrate that translocated 
YopD can accumulate at lysosomes. Additionally, deletion of the five Gbps found on 
chromosome 3 prevents activation of the inflammasome in response to Yersinia’s T3SS 
in a manner similar to caspase-11 deletion. Our findings suggest a cooperative role for 
YopD and Gbps. However, it is still unknown whether YopD is the direct signal or if YopD 
and Gbps work together to release a different Yersinia molecule such as Lipid A into the 
cytosol from the lysosome. 
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4) To investigate how the T3SS secreted effectors and structural components work 
together to evade the inflammasome and bacterial clearance. 
 
It has been shown that deletion of YopK is sufficient to allow for caspase-1/11 mediated 
attenuation of infection in vivo; however, the mechanism by which YopK prevents 
inflammasome activation has not been directly determined. Work described previously in 
this dissertation as well as by Kwuan et al. 2013 demonstrated that pore-formation is 
insufficient to activate the inflammasome. This suggests a model where YopK inhibits 
inflammasome activation by inhibiting translocation of the pore-proteins YopD and YopB. 
In Chapter 5, we use a combination of non-functional YopK mutants as well as T3SS 
chaperone protein mutants to investigate whether the ability of YopK to inhibit the 
inflammasome is solely dependent upon its ability to limit YopD and YopB translocation. 
Interestingly, we learned that the T3SS and its related proteins make up a finally tuned 
system that is kept in delicate balance. Small changes destroy the balance and cause 
attenuation of the infection by triggering various immune responses depending on how 
the balance changed. 
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CHAPTER 2 
MATERIALS AND METHODS 
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Bacterial Strains and Growth Conditions 
Yersinia strains are described in Table 3-1 and Table 5-1. For infection of cultured cells, Yersinia 
were grown overnight with aeration in 2xYT broth at 26 °C. The bacteria were diluted into fresh 
2XYT containing 20 mM sodium oxalate and 20 mM MgCl2. Bacteria were grown with aeration for 
1 hour at 26 °C followed by 2 hours at 37 °C prior to infection. Wild-type Salmonella Typhimurium 
strain SL1344 was grown overnight with aeration in LB broth at 37 °C. The bacteria were diluted 
into fresh LB containing 300 mM NaCl. Bacteria were grown standing to induce SPI-1 expression. 
For infection of mice, Yersinia were grown overnight with aeration in 2xYT broth at 26 °C and 
diluted in PBS. 
 
Cell Culture and Infection Conditions 
Mice were housed in accordance with the guidelines of the University of Pennsylvania 
Institutional Animal Use and Care Committee (IACUC). All studies involving mice were performed 
in accordance with University of Pennsylvania IACUC approved protocols. Bone marrow (BM) 
cells were grown for 7-8 days in DMEM containing Hepes, 10% Fetal Bovine Serum (FBS), and 
30% L929 supernatant in a humidified incubator. Differentiated BMDMs were replated overnight 
into 24-, 48-, or 96-well dishes. IFNγ primed macrophages were treated with 100 Units/mL 
recombinant IFNγ. Gbpchr3-/- BM was provided by Eric Feeley and Jörn Coers (Duke University, 
Durham, NC). Casp1-/- BM was provided by Till Strowig and Richard Flavell (Yale University, New 
Haven, CT). Casp11-/- was initially made by Junying Yuan (Harvard University) and kindly 
provided to us by Tiffany Horng (Harvard University). 
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Mouse infections 
Mouse infections were performed as previously described (Brodsky et al., 2010) with minor 
changes. In brief, Eight- to ten- week-old age-and sex-matched mice were infected 
intraperitoneally with 2 x 104 bacteria. Mice were euthanized and the tissues harvested at 3-4 
days post-infection. Bacterial load was determined by plating dilutions of tissue homogenates. 
Hemolysis Assay  
Pore-formation was determined by hemolysis assay as previously described with minor 
modifications (Olsson et al., 2004). Briefly: sheep erythrocytes (RBCs) were infected with T3SS 
induced Yersinia at an MOI of 0.05 - 0.1 for 3 hours at 37 °C.  RBCs were then resuspended in 
150 µL of cold PBS and spun down at 4°C for 15 minutes. 100 µL of supernatant was transferred 
to a flat bottom plate and read for absorbance at 545 nm. Percent hemolysis was normalized to 
the parent strain. 
PI Uptake Assay  
HeLa cells were seeded 1x104/well overnight in a 12-well chamber slide. Cells were loaded for 45 
minutes with CellTracker Green (1:2000, ThermoFisher Scientific) and then washed with PBS. PI 
was added to media (1:200), and cells were infected at an MOI of 100. Gentamicin was added 2 
hours post infection. Cells were imaged 4 hours post infection using Leica DMI4000 with 
Yokagawa CSU-X1 Spinning Disk Confocal Attachment (10x objective). Images were then 
analyzed using Metamorph 7.6 to quantify PI positive cells. 
Translocation Assay 
 HeLa cells were plated in a clear bottom, black 96-well tissue culture plate (Greiner Bio one) 
overnight. Cells were infected at a MOI of 5 with Yersinia expressing beta-lactamase fused to 
YopE (Brodsky and Medzhitov, 2008), YopM, YopJ, or YopD (Dewoody et al., 2013) for 2 hours. 
Gentamicin was added. CCF4-AM was loaded into cells using LiveBLAzer-FRET B/G Loading Kit 
(ThermoFisher Scientific) for 1.5 - 2 hours. The fluorescence was read using Biotek Synergy plate 
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reader. The response ratio was then calculated using the formula (blue:green ratio)/(average 
negative blue:green ratio).  
Cell Death Assay 
 Cytotoxicity was assayed using a lactate dehydrogenase (LDH) release assay kit (Clontech). In 
brief, BMDMs were differentiated from bone marrow with 30% L929 supernatant media for seven 
days before being plated. They were then infected with an MOI of 10, 20, or 100 for 4 hours. In 
some cases, cells were primed for 3 – 4 hours with 500 ng/mL of LPS. 2.5mM ATP was added to 
primed cells as a control for NLRP3 inflammasome activation. After 1 hour gentamicin was 
added. Four hours post infection, the plate was spun down, and assayed for LDH release.   
Cytokine Production  
Cells were primed for 3 – 4 hours with 500 ng/mL of LPS. The cells were then infected as in the 
cytotoxicity assay. The supernatants and recombinant cytokine standards (R&D Systems) were 
collected and added to ELISA plates that had been coated overnight with purified IL-1α, IL-1β, or 
IL-6 purified antibodies (eBioscience). The cytokines were then detected with the corresponding 
biotin antibodies (eBioscience) for 1 hour at room temp. Streptavidin-horseradish peroxidase 
(HRP) (Fisher Scientific) was then added. The plates were developed with citric acid buffer with 
O-Phenylenediamine (Sigma Aldrich). 3 M sulfuric acid was used to stop the reaction. 
Absorbance was read at 490 nm.  
Western Blotting  
Western blots were performed as described previously (Brodsky et al., 2010). In brief, cell lysates 
were run on a 4%-12% gradient gel (caspase-1 blots, ThermoFisher Scientific) and transferred to 
a PVDF membrane. Membranes were blotted with the primary antibodies rabbit anti-mouse 
caspase-1 p10 antibody (SC-514, Santa Cruz), rat anti-mouse caspase-1 p20 (Genentech), and 
mouse anti-actin (Sigma) or anti-YopD, anti-YopB {Chung, 2014 #4;Noel, 2009 #66}, anti-β-
lactamase (QED Bioscience Inc), and anti-LcrV antibodies (kind a gift of Matthew Nilles, 
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University of North Dakota). Secondary antibodies were goat anti-rabbit (Jackson 
Immunoresearch), goat anti-rat (Jackson Immunoresearch), or horse anti-mouse HRP (Cell 
Signaling). Blots were developed with Pierce ECL Western Blotting Substrate (Fisher Scientific).  
 
Immunofluorescence staining  
BMDMs were plated 1.5-2x105/well on glass coverslips in 24-well plates overnight. Two hours 
prior to infection, cells were treated with z-YVAD-fmk (R&D Systems or SM Biochemicals LLC) to 
a final concentration of 25 µM. BMDMs were then infected with an MOI of 5 for 2 hours. mCherry 
expressing Yersinia were used instead of anti-Yersinia antibody for infections that required anti-
Gbp2 antibody. Cells were fixed in 4% paraformaldehyde prepared from 16% paraformaldehyde 
(Electron Microscopy Sciences) for 20 minutes at room temperature and then washed twice in 
PBS. Cells were permeabilized for 10 minutes at room temperature in 0.2% triton X-100 (Sigma) 
and washed once in PBS. Cells were blocked for 1 hour at room temperature or overnight at 4°C 
in 10% BSA-PBS. Coverslips were then inverted onto primary antibody cocktails on parafilm and 
incubated for 1 hour at 37°C. Mouse monoclonal antibodies against YopD (1:500) and YopB 
(1:500) and rabbit polyclonal antibody against total Yersinia have been described (Chung et al., 
2014; Grabenstein et al., 2004; Noel et al., 2009). Rabbit anti-caspase-1 p10 antibody (1:100) 
was from Santa Cruz. Hybridoma rat anti-LAMP1 (neat, Developmental Studies Hybridoma Bank 
at the University of Iowa) was used to distinguish lysosomes. Staining with rabbit anti-Gbp2 
(Coers Lab Duke University, Haldar et al., 2013) was performed either overnight at 4°C prior to 
the other stains or for 1 hour at 37°C with the other primary antibodies if also staining with FAM-
FLICA. Coverslips were washed and stained with appropriate combinations of goat anti-mouse 
Alex488 (ThermoFisher Scientific), goat anti-rabbit Alexa568 (ThermoFisher Scientific), goat anti-
rabbit Alexa488 (ThermoFisher Scientific), goat anti-mouse Alexa647 (ThermoFisher Scientific), 
and goat anti-rat Alexa647 (Jackson Immunoresearch). Coverslips were washed 4 times. 
Coverslips were then stained with either a cocktail of Hoechst (1:1000, ThermoFisher Scientific) 
	  
	  
29	  
and Phalloidin Alexa647 (1:40, ThermoFisher Scientific) for 1 hour at 37°C or HCS CellMask Blue 
stain (ThermoFisher Scientific) for 1 hr at room temperature. Coverslips were then washed 4 
times. Coverslips were mounted on glass slides with FluoromountG (Southern Biotech). Cells 
were imaged with a Leica SP5 inverted confocal microscope and analyzed using Metamorph 7.6 
or Volocity 6.3. 
 
For FAM-FLICA staining for active caspase-1, BMDMs were plated 1.5-2x105/well on glass 
coverslips in 24-well plates overnight. FAM-FLICA (Immunochemistry Technologies) was added 1 
hour post infection. The rest of the protocol proceeded as above described. 
 
Metamorph Analysis  
Analysis of translocation in single cells was performed by first compressing all individual z-plane 
stacks into a single ‘maximum projection’. This enables analysis of the total area in the cell 
occupied by translocated protein. The final image was segmented into individual cells based on 
analysis of nuclear and actin staining. Each defined cell was converted into a region and 
transferred onto images of YopD and caspase-1 staining. Thresholds for positive and negative 
signal were set based on no primary antibody, uninfected, and ΔyopB or ΔyopD-infected control 
samples. The images were then analyzed for the intensity and area of staining in the regions. To 
quantify the amount of YopD not associated with bacteria, the area defined by YopD and/or 
bacterial staining was separated into whether pixels in that specific region were positive or 
negative for staining, and areas of YopD and bacterial overlap were determined. Areas of the cell 
determined to contain both YopD and bacterial staining were subtracted from total YopD staining. 
The degree of YopD staining was determined in pre- and post-subtraction images, and percent of 
bacteria-free YopD was calculated on a per cell basis by the area occupied by YopD post-
subtraction by the area occupied by YopD before subtraction.  
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Volocity Analysis  
Analysis of microscopy images was performed on 3D reconstructions of the z-stacks. Single cells 
were identified with the find object function based on CellMask Blue staining. The images were 
then analyzed for staining of Yersinia, YopD, LAMP1, Gbp2, caspase-1 using the find objects 
function to generate populations for each stain. Thresholds for positive and negative signals were 
based on no primary, uninfected, and Gbp2 knockout control samples. To determine the amount 
of translocated YopD, the pixels in the regions defined by YopD and/or bacterial staining were 
separated into whether pixels in that specific region were positive or negative for each stain. 
Regions determined to be positive for both YopD and Yersinia staining were subtracted from the 
total YopD staining using the subtract function. The remaining pixels were assigned to the 
population translocated YopD. To determine the amount of colocalization between YopD and 
Gbp2, YopD, or LAMP1, or the colocalization between Gbp2 and caspase-1, the regions defined 
by translocated YopD, Gbp-2, Lamp1, or caspase-1 puncta staining were separated into whether 
pixels in that specific region were positive or negative for each stain of interest. Regions that 
contained both stains of interest were assigned to the new population using the intersect function. 
The different populations were then compartmentalized into the cells. A measurement table was 
made for each of the compartmentalized populations. Using the analysis feature, the volume of 
each population per cell was calculated. Percent translocated or colocalized YopD was 
determined by dividing the volume of translocated or colocalized YopD in a cell by the volume of 
total YopD in that cell.    
 
Statistical Analysis 
Statistical analysis was performed using Prism 6 (Graphpad Software, Inc). One way ANOVA 
followed by Tukey’s Multiple Comparison test was used for the analysis of data requiring multiple 
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comparisons. Otherwise, Unpaired Student’s t tests were used for the analysis with Welch’s 
correction in cases of unequal standard deviation.  
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CHAPTER 3 
Inflammasome activation in response to the Yersinia Type III Secretion System requires 
hyperinjection of translocon proteins YopB and YopD 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter appeared as a published peer-reviewed article titled “Inflammasome 
activation in response to the Yersinia Type III Secretion System requires hyperinjection 
of translocon proteins YopB and YopD” by Erin E. Zwack, Annelise G. Snyder, Meghan 
A. Wynosky-Dolfi, Gordon Ruthel, Naomi M. Philip, Melanie M. Marketon, Matthew S. 
Francis, James B. Bliska, and Igor E. Brodsky. mBio, 2015.  
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Abstract: 
Type III Secretion Systems (T3SS) translocate effector proteins into target cells in order to disrupt 
or modulate host cell signaling pathways and establish replicative niches. However, recognition of 
T3SS activity by cytosolic Pattern Recognition Receptors (PRRs) of the Nucleotide-Binding 
Domain Leucine Rich Repeat (NLR) family, either through detection of translocated products or 
membrane disruption, induces assembly of multiprotein complexes known as inflammasomes.  
Macrophages infected with Yersinia pseudotuberculosis strains lacking all known effectors or 
lacking the translocation regulator YopK induce rapid activation of both the canonical NLRP3 and 
non-canonical caspase-11 inflammasomes. While this inflammasome activation requires a 
functional T3SS, the precise signal that triggers inflammasome activation in response to Yersinia 
T3SS activity remains unclear. Effectorless strains of Yersinia as well as ΔyopK strains 
translocate elevated levels of T3SS substrates into infected cells. To dissect the contribution of 
pore-formation and translocation to inflammasome activation, we took advantage of variants of 
YopD and LcrH that separate these functions of the T3SS. Notably, YopD variants that abrogated 
translocation but not pore-forming activity failed to induce inflammasome activation. Furthermore, 
analysis of individual infected cells revealed that inflammasome activation at the single cell level 
correlated with translocated levels of YopB and YopD themselves. Intriguingly, LcrH mutants that 
are fully competent for effector translocation but produce and translocate lower levels of YopB 
and YopD also fail to trigger inflammasome activation. Our findings therefore suggest that hyper-
translocation of YopD and YopB is linked to inflammasome activation in response to the Yersinia 
T3SS.   
 
Importance 
The innate immune response is critical to effective clearance of pathogens. Recognition of 
conserved virulence structures and activities by innate immune receptors such as NLRs 
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constitute one of the first steps in mounting the innate immune response. However, pathogens, 
such as Yersinia actively evade or subvert components of host defense, such as inflammasomes. 
The T3SS secreted protein YopK is an essential virulence factor that limits translocation of other 
Yops, thereby limiting T3SS-induced inflammasome activation. However, what triggers 
inflammasome activation in cells infected by YopK-deficient Yersinia is not clear. Our findings 
indicate that hyper-translocation of pore complex proteins promotes inflammasome activation and 
that YopK prevents inflammasome activation by the T3SS by limiting translocation of YopD and 
YopB themselves.  
 
Introduction 
The innate immune system plays a crucial role in host defense against pathogens. Pattern 
recognition receptors (PRRs) recognize conserved microbial structures expressed by both 
pathogenic and nonpathogenic bacteria, commonly termed pathogen associated molecular 
patterns (PAMPs) (Janeway, 1989; Janeway and Medzhitov, 2002). Cytosolic receptors that 
detect both virulence activities as well as bacterial molecules within the cytosol, which generally 
occurs as a direct consequence of pathogen virulence machinery activities, provide an additional 
layer of sensing of pathogenic bacteria (Vance et al., 2009).  
 
Virulence activities such as pore-formation by toxins or secretion systems, and delivery of 
bacterial products into the cytosol of target cells trigger the activation of a cytosolic immune 
surveillance pathway that culminates in assembly of multiprotein complexes termed 
inflammasomes (Brodsky and Monack, 2009; Lamkanfi and Dixit, 2009). Inflammasome 
assembly typically requires a nucleotide binding domain leucine-rich repeat protein (NLR), which 
responds to particular pathogen-associated stimuli, and induces oligomerization of apoptosis-
associated speck-like protein (ASC) and the cysteine protease caspase-1 (Lamkanfi and Dixit, 
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2009; Martinon et al., 2002). Inflammasome activation results in pyroptosis, a programmed cell 
death characterized by caspase-1 processing and the release of IL-1 family cytokines, IL-1α, IL-
1β, and IL-18 (Cookson and Brennan, 2001).  Additionally, a recently described non-canonical 
inflammasome also engages caspase-11 to induce cytotoxicity and IL-1α and contributes to 
maximal IL-1β processing and secretion by caspase-1 (Broz et al., 2012; Gurung et al., 2012; 
Kayagaki et al., 2011; Rathinam et al., 2012). 
 
Different inflammasomes respond to distinct signals. The NLRP3 inflammasome recognizes 
endogenous indicators of tissue damage and tissue stress, such as extracellular ATP and sodium 
urate crystals as well as microbial products such as viral and bacterial pore-forming proteins 
{Hornung et al., 2008; Kanneganti et al., 2006; Lamkanfi and Dixit, 2009; Mariathasan et al., 
2006; Martinon et al., 2006), whereas NLRC4 in conjunction with the NLR family apoptosis 
inhibitory protein (NAIP) proteins detects the presence of cytosolic flagellin and structurally similar 
products of the type III secretion system (T3SS) itself, such as PrgJ (Gong and Shao, 2012; Miao 
et al., 2006; Miao et al., 2008; Miao et al., 2010; Roy and Zamboni, 2006; Tenthorey et al., 2014; 
Yang et al., 2013). Recognition of pathogen-specific signals by inflammasomes promote anti-
microbial defense either via the immunological effects of IL-1 family cytokines (Casson et al., 
2013; Ichinohe et al., 2009) or through induction of pyroptosis (Miao et al., 2010a). 
 
The pathogenic Yersiniae, Yersinia pseudotuberculosis, Yersinia enterocolitica, and Yersinia 
pestis express a conserved T3SS that injects Yersinia Outer Proteins (Yops) into target cells 
(Cornelis and Wolf-Watz, 1997). Once inside the cell, the Yops disrupt a number of cellular 
processes including actin cytoskeleton rearrangement, protein phosphorylation, and NF-κB and 
MAPK signaling (Viboud and Bliska, 2005; Palmer et al., 1998). Two Yops, YopK and YopM, 
modulate inflammasome activation, thereby interfering with host innate immune defense and 
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promoting Yersinia infection (Brodsky et al., 2010; Chung et al., 2014; LaRock and Cookson, 
2012).  
 
Once translocated into the cell, YopK interacts with integral membrane components of the 
translocation complex, YopD and YopB, to prevent hyper-translocation of other Yops (Brodsky et 
al., 2010; Holmstrom et al., 1997; Thorslund et al., 2011). YopK may therefore limit translocation 
of other Yops by physically blocking or modulating the size of the translocon pore. YopK may also 
limit translocation by interacting with the host scaffolding protein RACK1 or potentially other 
cellular factors (Dewoody et al., 2013; Thorslund et al., 2011). In addition to a hyper-translocation 
of effectors, yopK mutants exhibit inflammasome-dependent attenuation in animal infections, 
indicating that inappropriate translocation of other Yops or additional factors triggers 
inflammasome activation, and leads to bacterial clearance in vivo (Brodsky et al., 2010). 
Interestingly, NLRP3, not NLRC4 is the primary driver of inflammasome activation in response to 
the Yersinia T3SS, in contrast to several other bacterial pathogens, such as Salmonella, likely 
due to inverse regulation of flagellin and T3SS expression in Yersinia (Brodsky et al., 2010; Miao 
et al., 2006; Minnich and Rohde, 2007). 
 
The YopB and YopD proteins are integral membrane proteins that form the translocon pore 
through which other Yops are delivered into the host cell. Thus, complete deletion of either YopB 
or YopD results in a nonfunctional T3SS (Neyt and Cornelis, 1999; Nordfelth and Wolf-Watz, 
2001; Rosqvist et al., 1995; Sory and Cornelis, 1994).  However, specific in-frame deletions in 
YopD result in loss of translocation ability while maintaining pore-forming activity (Olsson et al., 
2004). Conversely, mutations in the YopB and YopD chaperone, LcrH, impact pore-forming 
capacity due to reduced steady-state expression levels of YopB and YopD, yet maintain wild-type 
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levels of translocation, implying that pore-formation and translocation are separable biological 
features of the T3SS (Edqvist et al., 2007).   
 
Intriguingly, in addition to forming the translocation pore through which the classical effector Yops 
are injected into host cells, YopB and YopD themselves are also translocated into the host cell, 
albeit at relatively low levels in WT Yersinia (Dewoody et al., 2013; Francis and Wolf-Watz, 1998). 
The functional consequences of this translocation of components of the T3SS pore complex are 
not well understood but appear to be a general feature of the T3SS as Salmonella SipC and SipB 
pore complex proteins are also translocated (Collazo and Galan, 1997).  
 
Critically, the mechanism by which the Yersinia T3SS induces NLRP3 inflammasome activation 
remains unclear. As both pore-forming toxins and translocated bacterial products can cause 
inflammasome activation (Kanneganti et al., 2006; McNeela et al., 2010; Mitoma et al., 2013; 
Craven et al., 2009}, inflammasome activation could potentially be the result of pore-formation 
generated by the insertion of the pore complex or due to translocation of a molecule by the T3SS.  
 
Here we employed the YopD and LcrH mutants that separate pore-formation and translocation 
activities, and find that pore-formation is not sufficient to activate the inflammasome, consistent 
with recent observations (Kwuan et al., 2013). Strikingly, we also note that while translocation 
competence is required for inflammasome activation, it is not sufficient, as LcrH mutants with a 
functional translocon that display wild-type levels of effector Yop translocation but do not 
translocate detectable levels of YopB or YopD fail to trigger inflammasome activation. Moreover, 
hyper-translocation of YopB and YopD correlated with an increased likelihood of caspase-1 
activation at the single-cell level. These findings suggest that the translocation of YopB and/or 
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YopD may mediate inflammasome activation in response to the Yersinia T3SS, and that YopK 
functions to prevent excessive translocation of these proteins.  
 
Results 
Translocation is required for inflammasome activation in response to Yersinia 
T3SS  
Translocation of currently undefined T3SS client proteins may be responsible for NLRP3 
inflammasome activation in macrophages by the Yersinia T3SS (Brodsky et al., 2010; Kwuan et 
al., 2013). Alternatively, alteration in the stoichiometry, conformation, or pore-forming properties 
of the translocon components YopB and YopD could be responsible. In order to dissect the 
relative contributions of translocation and pore-formation of the T3SS to inflammasome activation, 
we generated in-frame yopD deletion mutants in a Y. pseudotuberculosis strain lacking Yops E, J, 
and K (ΔyopEJK), which induces robust T3SS-dependent NLRP3 inflammasome activation in 
murine macrophages. These in-frame deletion mutations in yopD separate the pore-forming and 
translocation activities of YopD in wild-type Yersinia (Olsson et al., 2004). 
 
To accurately determine bacterially induced pore-formation and differences in translocation, we 
performed translocation and pore-formation assays with HeLa cells and sheep red blood cells 
that do not undergo inflammasome-mediated cell death in response to infection. We observed 
that deletion of amino acids 4-20 or 53-68 (termed YopDΔ1 and YopDΔ3 respectively) completely 
abrogated translocation of a YopE-β-lactamase reporter construct similarly to what is seen with 
ΔyopB or YopDΔ4 (aa 73-90), which have been previously demonstrated to generate 
nonfunctional T3SS. In contrast, YopDΔ7 (150-170) maintained translocation although at a 
reduced level compared to YopDWT (Fig. 3-1A). Pore-formation as measured by hemolysis in 
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sheep red blood cells was significantly reduced in YopDΔ1, YopDΔ3, and YopDΔ7 in comparison 
to YopDWT. However, these variants still caused significant levels of pore-formation relative to 
ΔyopB and YopDΔ4, which eliminated the hemolytic capacity of the T3SS (Fig. 3-1B). To address 
potential threshold effects resulting from the reduced pore-forming activity of YopDΔ1 and 
YopDΔ3, we performed our macrophage infections at both a MOI of 20 and a MOI of 100. 
Critically, at both MOIs, YopDΔ1 and YopDΔ3 failed to induce IL-1β secretion, LDH release, or 
cleavage of caspase-1, suggesting that eliminating translocation abrogated the ability of the 
Yersinia T3SS to induce inflammasome activation (Fig. 3-1C-E). Differential secretion of IL-1β in 
response to different YopD variants was not due to effects of YopD on TLR signaling per se, as 
secretion of IL-6 was unaffected in response to infection with different YopD variants (Fig. 3-1E). 
Interestingly, while YopDΔ1, Δ3 and Δ7 were all capable of inducing hemolysis in RBCs, they did 
not induce propidium iodide (PI) uptake in HeLa cells, another measure of “pore formation”, 
implying that this pore formation, at least in nucleated cells, is distinct from the T3SS pore itself 
(Fig. 3-2) Together, these data suggest that pore-forming capacity of the Yersinia T3SS is 
insufficient to induce inflammasome activation; rather, that translocation of an unknown molecule 
induces NLRP3 inflammasome activation. 
 
Deletion of yopK results in hyper-translocation of YopD and YopB  
Our data and previously published work (Brodsky et al., 2010; Dewoody et al., 2011; Dewoody et 
al., 2013; Holmstrom et al., 1997; Olsson et al., 2004) suggest that YopK normally functions to 
regulate translocation by the T3SS, and that the hyper-translocation taking place in the absence 
of YopK triggers inflammasome activation. The integral translocon components YopB and YopD 
are also translocated during infection, raising the possibility that excess translocation of YopD or 
YopB themselves might be responsible for T3SS-induced inflammasome activation (Dewoody et 
al., 2013; Francis and Wolf-Watz, 1998). To determine whether YopB and YopD translocation 
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might be correlated with inflammasome activation, we performed confocal microscopy on 
Yersinia-infected macrophages and analyzed both the translocation of T3SS pore complex 
proteins and caspase-1 puncta formation. Macrophages were treated with YVAD-fmk to enhance 
puncta visualization by preventing death of the macrophages or escape of caspase-1 from the 
puncta. Formation of caspase-1 puncta indicates oligomerization of caspase-1, and is an 
indicator of inflammasome formation (Broz et al., 2010). Confocal fluorescence microscopy 
analysis of YopD translocation revealed a significant correlation between the degree of YopD 
translocation, defined by intensity and area of anti-YopD staining, and the formation of caspase-1 
puncta (Fig. 3-3). A similar correlation was found for YopB (Fig. 3-4). Infection with ΔyopEJK 
resulted in a significantly elevated percentage of puncta positive cells than infection with ΔyopEJ, 
consistent with previous studies that showed YopK prevents inflammasome activation (Brodsky et 
al., 2010). Interestingly, YopB and YopD accumulated in the cytosol in large punctate or vesicular 
structures that were devoid of bacteria (Fig. 3-3D-E). Both the extent (area) and percent of 
cytosolic YopD were significantly elevated in the absence of YopK. We did not observe co-
localization of either YopD or YopB with the caspase-1 puncta themselves, implying that any role 
of YopB or YopD in inflammasome activation was not the result of direct recognition by NLRP3. 
 
Translocation is not sufficient for T3SS-induced inflammasome activation  
To further test the possibility that YopD or YopB translocation might be responsible for 
inflammasome activation, we generated two separate LcrH mutants designated lcrHmut1 
(encoding LcrHY40C, I101M, K102R) and lcrHmut2 (encoding LcrHQ46R, F72S, Q81R, H162R) as well as the 
lcrH null mutant (ΔlcrH) in the ΔyopEJK strain background. LcrH is a chaperone for both YopB 
and YopD, and specific amino acid mutations in LcrH lead to reduced steady-state levels of 
stable YopB and YopD without affecting the translocation of other Yops (Edqvist et al., 2007). 
Consistent with established work that these amino acid changes in LcrH affect the T3SS, both 
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lcrHmut1 and lcrHmut2 expressed and secreted lower levels of YopB and YopD (Fig. 3-5A and 
B), but did not affect the translocation of a YopE-β-lactamase reporter (Fig. 3-5D). Furthermore, 
lcrHmut1 also had no effect on translocation of a YopM-β-lactamase reporter, demonstrating that 
these LcrH mutants do not impact translocation of secreted effector Yops. Importantly, another 
structural component of the T3SS, LcrV, as well as YopE-β-lactamase, were expressed to an 
equal extent in the bacteria themselves, but exhibited a hypersecretory phenotype in the lcrH 
mutant strain backgrounds, consistent with previous observations that LcrH mutations or 
translocon mutations that reduce expression of YopD or YopB result in hypersecretion (Anderson 
et al., 2002; Edqvist et al., 2006; Wattiau et al., 1994; Williams and Straley, 1998)(Fig. 3-5A and 
B). Critically, the lcrHmut1 and ΔlcrH strains were unable to translocate YopD-β-lactamase (Fig. 
3-5E).  Despite translocating effector Yops in a manner that was indistinguishable from wild-type 
bacteria, both lcrHmut1 and lcrHmut2 strains failed to trigger macrophage cytotoxicity and IL-1β 
secretion (Fig. 3-5E and F). Collectively these data suggest that hyper-translocation of LcrH-
dependent pore-complex proteins is required for inflammasome activation. 
Hyper-translocation of YopD is necessary for caspase-1 puncta formation 
To test the contribution of translocated YopD and YopB to inflammasome activation, we 
examined inflammasome activation in the context of lcrHmut1 as this mutant had reduced steady-
state levels of YopB and YopD but the reduction was not as great as in lcrHmut2 (Fig. 3-5A). 
Notably, confocal microscopy analysis of individual Yersinia-infected cells demonstrated that 
lcrHmut1 Yersinia strains translocated significantly lower levels of YopD than wild-type Yersinia, 
as quantified by intensity and area of antibody staining, in accordance with our findings using the 
YopD-β-lactamase reporter (Fig. 3-6A-C). Critically, this reduced translocation of YopD was 
linked to loss of inflammasome activation, as a significantly higher percentage of ΔyopEJK 
Yersinia-infected cells exhibited evidence of caspase-1 puncta in comparison with lcrHmut1-
infected cells (Fig. 3-6D).  Translocation of YopB was similarly reduced in lcrHmut1-infected cells, 
and no caspase-1 puncta were observed (Fig. 3-4). Altogether, our data support a model in which 
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excess translocation of YopD and/or YopB triggers NLRP3 inflammasome activation. Although an 
additional T3SS-translocated product that is inappropriately translocated in the absence of YopK 
may also lead to NLRP3 inflammasome activation, the lack of inflammasome activation by 
specific LcrH mutants that limit translocation of Yops D and B without impacting translocation of 
other T3SS substrates indicates that YopD and/or B play a critical role in triggering this response.  
 
Discussion 
Inflammasome activation plays a key role in inflammatory responses during infection or disruption 
of tissue homeostasis, and distinct NLR proteins respond to different inflammatory triggers such 
as the presence of microbial products within the cytosol of target cells. The NLRP3 
inflammasome is triggered by structurally diverse microbial and stress-associated signals (Allen 
et al., 2009; Ichinohe et al., 2009; Iyer et al., 2013; Kanneganti et al., 2006; Kim et al., 2013; 
Mariathasan et al., 2006; McNeela et al., 2010; Menu et al., 2012; Shimada et al., 2012; Shio et 
al., 2009; Zhou et al., 2011), and previous studies demonstrated that the Yersinia type III 
secretion system can trigger NLRP3 inflammasome activation in the absence of all known 
secreted effectors (Brodsky et al., 2010). Several studies have demonstrated that in the absence 
of YopK, a secreted Yersinia effector protein that negatively regulates the translocation activity of 
the T3SS, NLRP3 inflammasome activation is significantly enhanced (Brodsky et al., 2010; 
Kwuan et al., 2013; LaRock and Cookson, 2012). However, the mechanism by which the NLRP3 
inflammasome is triggered by the Yersinia T3SS is unknown. 
 
Interactions between the Yersinia virulence machinery and inflammasome activation involve an 
intricate interplay between Yersinia effector proteins, TLR signaling, and innate immune 
pathways. In the context of NF-κB and MAPK blockade by YopJ, cells such as naïve 
macrophages trigger a distinct form of caspase-1 activation that engages the cell extrinsic death 
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pathway and promotes anti-Yersinia immune defense independently of known inflammasome 
components (Monack et al., 1997; Philip et al., 2014). Interestingly, LPS-primed macrophages do 
not undergo YopJ-induced caspase-1 activation, possibly as a result of inhibition of caspase-1 
activation by YopM (Chung et al., 2014; LaRock and Cookson, 2012). However, in the absence of 
all known effector Yops or in the absence of Yops J and K alone, the Yersinia T3SS triggers a 
robust NLRP3 inflammasome activation that involves both canonical and non-canonical 
inflammasomes in both LPS-primed and unprimed macrophages (Bergsbaken and Cookson, 
2007; Brodsky et al., 2010; Casson et al., 2013; Shin and Cornelis, 2007). The mechanism by 
which the Yersinia T3SS induces this NLRP3 inflammasome activation in the absence of all 
known secreted effectors remains unclear. 
 
The various activities of the T3SS have been extensively probed by taking advantage of bacterial 
genetic tools to generate mutants deficient in key components of the translocon and associated 
proteins (Edqvist et al., 2007; Olsson et al., 2004). In particular, in-frame deletions in the integral 
translocon component YopD make it possible to separate the pore-forming ability of the 
translocon from the capacity of the T3SS to translocated effector proteins (Olsson et al., 2004). 
Specifically, deletion of amino acids 4-20 or 53-68 in YopD compromises the ability of the T3SS 
to translocate effectors, but has a minimal impact on the ability of the T3SS to induce hemolysis 
in sheep RBCs, one measure of pore-forming ability ((Olsson et al., 2004) and Fig. 3-1A). 
Interestingly, we found that these YopD deletion mutants failed to induce inflammasome 
activation, despite being able to lyse RBCs, consistent with recent findings by Kwuan et al., that 
pore formation is insufficient to induce inflammasome activation (2013).  Thus, some structural 
feature of the translocation process and/or a particular translocated molecule(s) is the cue for 
inflammasome activation.  
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Indeed we found that translocation is necessary but insufficient for NLRP3 inflammasome 
activation, as mutations in the T3SS chaperone gene lcrH that do not affect YopE or YopM 
translocation, but are not capable of forming pores in RBCs, are also incapable of triggering 
inflammasome activation. Critically, our data show that LcrH mutant Yersinia that produce a 
functional translocon in the presence of limited YopB and YopD proteins, have a specific defect in 
translocation of YopD and YopB. Single-cell-based analyses of YopD and YopB translocation 
revealed a significant correlation between the extent of translocation of these proteins and the 
formation of an active inflammasome complex. 
 
Taken together, these studies suggest that hyper-translocation of YopD or YopB in the absence 
of YopK is responsible for NLRP3 inflammasome activation. An alternative possibility is that 
structural differences in the translocon resulting from mutation of LcrH or YopD alters the 
membrane-perturbing properties of the translocon. While the YopDΔ1, Δ3, and Δ7 mutants are all 
capable of inducing RBC lysis, we did not detect measurable PI uptake in HeLa cells infected with 
these mutants (Fig. 3-2). These data suggest that membrane perturbation or lysis in different cell 
types involves distinct features of the translocon. Indeed, neither of the LcrH mutants used in this 
study induce RBC lysis, despite being fully competent for translocation ((Edqvist et al., 2007) and 
Fig. 3-5). These data suggest that pore formation measured by leakage of dyes across eukaryotic 
cell membranes during Yersinia infection detects the presence of a host cell-derived pore that is 
assembled or activated in response to the activity of the T3SS. Whether this pore is itself 
dependent on caspase-1 activation (Fink and Cookson, 2006) or is responsible for mediating 
caspase-1 activation, or whether this system constitutes a self-amplifying positive-feedback loop, 
remains to be determined.  
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How translocation of YopD or YopB is linked to NLRP3 inflammasome activation is currently 
unclear. YopD and YopB are both amphipathic and membrane-active, raising the possibility that 
at elevated concentrations in the target cell, insertion of one or both of these proteins into 
membranes of cellular organelles may induce inflammasome activation. Disruption of lysosomal 
membranes or Golgi membranes has been linked to NLRP3 inflammasome activation (Hornung 
et al., 2008; Ichinohe et al., 2010; Ito et al., 2012) raising the possibility that insertion of YopD or 
YopB into these membranes triggers NLRP3. We observed large aggregates or superstructures 
of YopD and YopB in cells infected by YopK-deficient Yersinia (Fig. 3-3 and 3-6 and Fig. 3-4). 
These structures were not simply the presence of YopD or YopB staining around the Yersinia, as 
a significant percentage of these structures were not associated with intact bacteria (Fig. 3-3). 
Protein aggregates or crystals are known to induce NLRP3 inflammasome activation; large 
aggregates of YopB or YopD could therefore lead to NLRP3 inflammasome activation. Future 
studies will dissect the molecular mechanism for NLRP3 activation by translocated YopD and/or 
YopB. 
 
It is possible that YopD and YopB translocation serves as a surrogate for elevated translocation 
of an unknown factor or protein that is more directly responsible for T3SS-induced inflammasome 
activation. While it remains possible that another protein or bacterial molecule is translocated by 
the Yersinia T3SS and induces NLRP3 activation, our data suggest that YopD and/or YopB 
translocation into the cytosol is responsible, and that YopK prevents the excessive translocation 
of YopD and YopB into target cells in order to avoid triggering this innate inflammatory response. 
Interestingly, initial studies of inflammasome activation by Salmonella suggested that 
microinjected SipB, the Salmonella homolog of YopB, induced caspase-1 activation (Hersh et al., 
1999). Thus, activation of the NLRP3 inflammasome by the bacterial T3SS machinery may be a 
broadly conserved innate response to the cytosolic presence of T3SS pore complex proteins. 
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Figure 3-1. Translocation is required for inflammasome activation by Yersinia T3SS. A. 
HeLa cells were infected with indicated strains expressing a YopE-β-lactamase fusion protein 
(YopE-Bla) or ΔyopEJK lacking the β-lactamase construct (ctrl). Cells were loaded with CCF4-AM 
dye, and the ratio of blue:green signal (translocation) was calculated as described in Materials 
and Methods. Results are representative of 3 independent experiments. B. Sheep red blood cells 
were infected with indicated YopD deletion mutants or the controls ΔyopB and ΔyopEJK. 
Supernatants were assayed for release of hemoglobin as described in Materials and Methods. 
The graph is representative of two to four independent experiments with independent 6 replicates 
per sample. C. BMDMs were infected with indicated YopD deletion mutants, ΔyopB, or ΔyopEJK 
or treated with LPS or LPS + ATP, and cytotoxicity was determined by LDH release. The graph is 
of a representative experiment from one of five independent experiments (MOI 20) or 2 
independent experiments (MOI 100) with 3 replicates per sample. D. BMDMs were infected with 
the indicated bacterial strains or treated with LPS or LPS + ATP. Cell lysates were assayed for 
pro- and processed caspase-1 and actin as indicated. E. Supernatants from BMDMs infected with 
indicated bacterial strains were assayed for levels of secreted IL-1β and IL-6 by ELISA as 
described in Materials and Methods. **** p<0.0001.  
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Figure 3-2. In-frame YopD deletions eliminate pore formation in HeLa cells independent of 
translocation and hemolysis. HeLa cells were infected at an MOI of 100 with the indicated 
YopD mutants or the controls ΔyopEJKD and ΔyopEJK in the presence of PI for 2 hours prior to 
the addition of gentamicin. Images were taken 2 hours post gentamicin addition. Images were 
analyzed for the percent of HeLa cells containing PI. Data pooled from three independent 
experiments. **** p<0.0001.  
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Figure 3-3. Increased YopD translocation correlates with activation of caspase-1. A. 
Combined z-stacks of confocal microscopy images of BMDMs that were pretreated with YVAD 
and left uninfected or infected with ΔyopEJK or ΔyopEJ for 2 hrs. Cells were stained for YopD 
(green), caspase-1 (red), and DNA (blue). Arrows denote caspase-1 puncta. B. Total area of 
YopD (µm2) in caspase-1 puncta positive cells versus caspase-1 puncta negative cells in 
ΔyopEJK infection.  Total intensity of YopD staining for caspase-1 puncta positive cells versus 
caspase-1 puncta negative cells infected with ΔyopEJK. Each point represents a single cell. C. 
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Percent of YopD staining cells that were positive for caspase-1 puncta. D. Combined z-stacks of 
confocal microscopy images of cells that were uninfected or infected with ΔyopEJK or ΔyopEJ for 
2 hrs. Cells were stained with antibodies against YopD (green), Yersinia (red), and Hoechst to 
visualize DNA (blue). Amount of cytosolic YopD was determined as described in Materials and 
Methods. E. Percent and total area of cytosolic YopD (µm2) obtained from analyzing microscopy 
images as in D. (B,C,E) Each point represents a single cell, data are pooled from 3 independent 
experiments. Red lines represent mean of data. Scale bars are 10 µm. (B,C) 477 individual cells 
were analyzed. (E) 321 individual cells were analyzed. * p< 0.05, ** p< 0.005, *** p < 0.0005. 
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Figure 3-4. Increased translocation of YopB correlates with caspase-1 activation. A. 
Combined z-stacks of confocal microscopy images of YVAD-pretreated BMDMs that were left 
uninfected or infected with ΔyopEJK or ΔyopEJK-lcrHmut1 for 2 hrs. Cells were stained for YopB 
(green), caspase-1 (red), and DNA (blue). White arrows indicate active caspase-1 puncta. B. 
Total area (µm2) and total intensity of YopB staining in cells infected with ΔyopEJK (circles) or 
ΔyopEJK-lcrHmut1 (squares). Data pooled from at least three independent experiments 
respectively. Each point represents a single cell. 646 individual cells were analyzed.  Red bars 
indicate mean of data. C. Percent of YopB staining cells that contain active caspase-1 puncta. 
Scale bars are 10 µm. (B)  One-way ANOVA with Tukey Multiple Comparison tests ** p< 0.005, 
*** p < 0.0005 **** p< 0.0001  (C) Student’s t-test **** p< 0.0001. 
	  
	  
54	  
 
	  
	  
55	  
Figure 3-5. Minimal translocon is insufficient for inflammasome activation by Yersinia 
T3SS A. TCA precipitated bacterial supernatants and bacteria pellet from inducing cultures were 
probed for YopD, YopE-β-lactamase, and LcrV. ΔyopEJKBD strain lacking YopE-Bla construct 
was used as a control. B. YopB and LcrV. C. HeLa cells were infected with lcrH wild-type, point 
mutant, or deletion strains, as indicated, or ΔyopB control strains expressing YopE-Bla. ΔyopEJK 
lacking the YopE-Bla plasmid was used as a negative control (ctrl). Translocation was determined 
as described in materials and methods. Graph is of a representative experiment from one of three 
independent experiments with 3 replicates per treatment per experiment. D. HeLa cells were 
infected with lcrH wild-type, point mutant, or deletion strains, as indicated, or ΔyopB control 
strains expressing YopM-Bla and YopD-Bla. Translocation was determined as described in 
Materials and Methods. Graph is a representative experiment from one of three independent 
experiments with 3 replicates per treatment per experiment.  E. Percent cytotoxicity was 
determined by assaying LDH in supernatants following infection of BMDMs with indicated 
bacterial strains, as in C, or treatment with LPS or LPS+ATP. F. ELISA for IL-1β or IL-6 from LPS 
primed BMDMs infected with indicated bacterial mutant strains, ΔyopB, or ΔyopEJK, or treated 
with ATP or media control alone. Representative graph from one of three independent 
experiments with 3 replicates per treatment. * p< 0.05, **** p< 0.0001  
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Figure 3-6. Hyper-translocation of pore complex proteins is necessary for inflammasome 
activation. A. Combined z-stacks of confocal microscopy images of YVAD-pretreated BMDMs 
that were left uninfected or infected with ΔyopEJK or ΔyopEJ for 2 hrs. Cells were stained for 
YopD (green), caspase-1 (red), and DNA (blue). White arrows denote active caspase-1 puncta. 
B. Total area of YopD staining (µm2) in cells infected with ΔyopEJK (circles) or ΔyopEJK-
lcrHmut1 (triangles). C. Total intensity of YopD staining in cells infected with ΔyopEJK (circles) or 
ΔyopEJK-lcrHmut1 (triangles). Each point represents a single cell.  1242 individual cells were 
analyzed. All data pooled from 3 independent experiments. Scale bars are 10 µm. D. Percent of 
cells with YopD staining that were positive for caspase-1 puncta. *** p < 0.0005, **** p<0.0001. 
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Table 3-1. Yersinia strains used in this study 
 
Strain Name Relevant Characteristics Reference or Source 
Y. pseudotuberculosis 
IP2666 (WT) 
 
ΔyopB 
 
Wild-type 0:3 strain 
 
Full deletion of translocon 
protein YopB on IP2666 
background 
 
Black and Bliska, 1997 
 
Palmer et al., 1998 
 
ΔyopEJ 
 
Full deletion of Yops E 
and J on IP2666 
background 
 
This work 
 
ΔyopEJK 
 
Full deletion of Yops E, J, 
and K on IP2666 
background 
 
This work 
 
yopBΔyopEJKD 
 
Point mutation causing a 
non-functional, truncated 
YopB on ΔyopEJKD 
background 
 
This work 
 
YopDΔ1 
 
In frame deletion of 
amino acids 4-20 on the 
ΔyopEJK background 
 
Olsson et al., 2004,  
This work 
 
 
YopDΔ3 
 
 
In frame deletion of 
amino acids 53-68 on the 
ΔyopEJK background 
 
 
Olsson et al., 2004,  
This work 
   
 
YopDΔ4 
 
In frame deletion of 
amino acids 73-90 on the 
ΔyopEJK background 
 
Olsson et al., 2004,  
This work 
 
YopDΔ7 
 
In frame deletion of 
amino acids 150-170 on 
the ΔyopEJK background 
 
Olsson et al., 2004,  
This work 
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lcrHmut1 LcrHY40C, I101M, K102R on 
ΔyopEJK background 
Edqvist et al. 2007,  
This work 
 
lcrHmut2 
 
LcrHQ46R, F72S, Q81R, H162R 
 
Edqvist et al. 2007,  
This work 
 
ΔlcrH 
 
Deletion of lcrH on 
ΔyopEJK background 
 
Edqvist et al. 2007,  
This work 
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 CHAPTER 4 
A role for guanylate binding proteins in activation of the inflammasome downstream of 
YopD hyperinjection 
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Abstract: 
The T3SS plays essential roles in the virulence of many bacteria by allowing for the delivery of 
bacterial effectors into the host cell. These effectors manipulate host cell processes to allow for 
enhanced survival of the bacteria. However, NLRs, a class of internal immune sensors, recognize 
a variety of stimuli such as translocated bacterial products and disruption of internal membranes 
and induce the formation of a multiprotein complex called the inflammasome. Additionally, a 
separate caspase-11-dependent inflammasome can also recognize infection. We recently 
determined that hyper-translocation of the Yersinia T3SS translocon pore proteins YopD and 
YopB is required for inflammasome activation in response to infection by T3SS expressing 
Yersinia in the absence of YopK (Zwack et al., 2015). However, the mechanism(s) through which 
YopD and YopB activate the inflammasome are unclear. Intriguingly, Yersinia infection is 
recognized predominantly by the non-canonical inflammasome with some contribution by the 
canonical inflammasome. We used confocal microscopy to determine that YopD can associate 
with lysosomes. Translocated YopD and translocation-competent Yersinia recruited Gbp2; 
suggesting translocated YopD damages lysosomes. Although recruitment of Gbp2 does not 
correlate with inflammasome activation on its own, deletion of the five Gbps found on 
chromosome 3 resulted in a decrease in inflammasome activation in response to Yersinia of a 
similar extent as caspase-11 deletion. Our findings suggest that YopD interacts with Gbps to 
activate the inflammasome either directly or indirectly through the release of another bacterial 
product.  
Introduction: 
	  
Innate immune recognition of pathogens plays a vital role in host defense. Surface and 
endosomal TLRs recognized conserved structures of pathogens. Signaling through TLRs leads to 
gene expression downstream of NFκB and MAPK. Intracellular receptors such as the NLRs 
recognize a combination of conserved virulence structures and virulence activities such as 
translocated flagellin and pore-formation. Activation of NLRs results in the formation of a multi-
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protein complex called the inflammasome. Assembly of the inflammasome is necessary for the 
activation of caspase-1 in response to certain infections. Activation of caspase-1 leads to the 
processing of IL-1β and IL-18, the secretion of IL-1α, IL-1β, and IL-18, and cell death through 
cleavage of GSDMD (Shi et al., 2015).  
 
In addition to the canonical inflammasome described above, there also exists a non-canonical 
inflammasome that causes GSDMD-mediated cell death and IL-1α secretion independently of 
caspase-1 (Fig. 1-2) (Kayagaki et al., 2015; Shi et al., 2015). The non-canonical inflammasome 
requires the activation of caspase-11. Caspase-11 then causes GSDMD cleavage and IL-1α 
secretion. Caspase-11 activation also leads to activation of the canonical NLRP3 inflammasome, 
which results in the processing and secretion of IL-1β and IL-18. In response to infection with 
gram-negative bacteria, Gbps have been demonstrated to play an important role in activating the 
caspase-11 inflammasome. Gbps have been described to function both at the lysosome as well 
as in the cytosol during non-canonical inflammasome activation by gram-negative bacteria and 
transfection of LPS (Meunier et al., 2014; Pilla et al., 2014). 
 
Bacterial secretion systems play an essential role during infection for many gram-negative 
bacteria. However, certain types of these systems such as the type III and type IV secretion 
systems introduce bacterial products that can interfere with host processes directly into the 
cytosol of cells. It has previously been demonstrated that the T3SS of Yersinia can be recognized 
by the inflammasome (Bergsbaken and Cookson, 2007; Brodsky et al., 2010). The human 
pathogenic Yersiniae, Yersinia pestis (Yp), Yersinia pseudotuberculosis (Yptb), and Yersinia 
enterocolitica (Ye), all encode what is considered an archetypal T3SS as well as associated 
effectors. The T3SS and its effectors are essential for Yersinia infection. In the absence of all 
known effectors, or minimally both the effectors YopJ and YopK, the T3SS of Yersinia activates 
	  
	  
63	  
the inflammasome. We recently demonstrated that translocation of the Yersinia T3SS translocon 
pore proteins YopD and YopB is required for this inflammasome activation downstream of 
Yersinia pseudotuberculosis infection in the absence of the T3SS effectors YopK and YopJ 
(Zwack et al, 2015). However, the mechanism(s) through which translocation of YopD and YopB 
activate the inflammasome are unclear. In this study we attempt to define a mechanism for 
inflammasome recognition of type III secretion system translocon proteins. As initial studies on 
activation of the inflammasome by the T3SS used Casp1Casp11 -/- bone marrow, we first 
considered the possibility that translocation of YopD and YopB were activating the non-canonical 
inflammasome. Here we demonstrate that the non-canonical inflammasome is the main but not 
sole inflammasome contributing to T3SS recognition. We also hypothesize that translocation of 
YopD leads to the insertion of YopD into internal membranes as YopD contains a transmembrane 
domain. Interestingly, we observed that YopD can accumulate at lysosomes. As Gbps are 
recruited to lysosomes that contain pathogens and have been described to function both at and 
downstream of lysosomes containing gram-negative bacteria to activate the inflammasome 
(Meunier et al., 2014; Pilla et al., 2014), we wanted to test whether Gbps would recognize YopD 
at lysosomes or the consequences of YopD colocalizing with lysosomes to activate the 
inflammasomes. We determined that Gbps play a role in the caspase-11 inflammasome 
activation downstream of YopD translocation. Based on our data, we propose a model for 
inflammasome activation during Yersinia infection where translocated YopD and YopB associate 
with lysosomes and release both host and bacterial products from the lysosomes. The Gbps act 
downstream of the YopD/B induced initial damage to the lysosomes to activate the non-canonical 
inflammasome. 
 
 
 
	  
	  
64	  
Results:  
Yersinia T3SS predominantly activates the caspase-11 non-canonical 
inflammasome 
Different stimuli activate the canonical and non-canonical NLRP3 inflammasome. Certain 
mechanisms can potentially be used in both pathways such as disruption of the lysosome while 
other mechanisms such as potassium efflux result only in activation of the canonical 
inflammasome activation pathway (Kayagaki et al., 2011; Meunier et al. 2014). To determine 
whether infection with Yersinia expressing a T3SS triggered non-canonical or canonical 
inflammasome activation, we infected BMDMs from B6, Casp1-/-, Casp11-/-, and Casp1Casp11-/- 
mice. As expected, treatment with LPS + ATP, a canonical NLRP3 inflammasome activator, 
caused robust death and IL-1β and IL-1α secretion in B6 and Casp11-/- BMDMs but not Casp1-/- 
or Casp1Casp11-/- BMDMs. BMDMs infected with ΔyopB Yersinia, which do not express a 
functional T3SS, did not die or secrete inflammasome dependent cytokines (Fig. 4-1 A-C). 
Interestingly, in comparison to B6 BMDMs, infection with ΔyopEJK Yersinia, which express a 
functional T3SS but are missing a subset of secreted effector proteins, caused a drastic decrease 
in cell death in Casp11-/- as well as Casp1Casp11-/-. A smaller but statistically significant 
decrease in death was observed in the Casp1-/- (Fig. 4-1A). As IL-1β processing and secretion 
require caspase-1 in both the canonical and non-canonical inflammasomes it was unsurprising to 
see complete abrogation of secretion in the Casp1-/- and Casp1Casp11-/- in response to ΔyopEJK 
Yersinia infections. While IL-1β secretion was drastically reduced in Casp11-/- BMDMs during 
infection, a substantial amount of IL-1β was still secreted (Fig. 4-1B). In contrast, Casp1-/- did not 
have a significant effect on IL-1α secretion during infection by ΔyopEJK (Fig. 4-1C). These data 
suggest that the non-canonical inflammasome plays the predominant role in recognition of T3SS 
expressing Yersinia but is not solely responsible for recognition of Yersinia. 	  
YopD can associate with the late endosome/lysosome marker LAMP1  
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We previously determined that translocation of the pore proteins YopD and YopB induces 
inflammasome activation in response to T3SS expressing Yersinia (Zwack et al., 2015). Confocal 
microscopy of ΔyopEJK infected BMDMs showed that YopD forms larger structures in the cell 
(Zwack et al., 2015). As YopD is membrane active and damage to lysosomes has been 
demonstrated to be important for both canonical and non-canonical inflammasome activation 
(Meunier et al., 2014; Hornung et al., 2008), we examined whether YopD colocalized with 
lysosomes. We performed confocal microscopy on BMDMs infected with mCherry expressing 
Yersinia to determine the extent of translocated YopD colocalization with LAMP1 expressing 
lysosomes (Fig. 4-2A). YopD did colocalize with lysosomes in both ΔyopEJK and ΔyopEJ 
infection as determined by the volume of translocated YopD that intersected with LAMP1 staining 
(Fig. 4-2B). Although the volume of translocated YopD colocalized with lysosomes was not 
significantly different between ΔyopEJK and ΔyopEJ infection (Fig. 4-2B), it is possible that the 
amount of YopD contained in that volume may differ. Interestingly, in both ΔyopEJK and ΔyopEJ 
infection, the percent of translocated YopD that colocalizes with lysosomes in a cell 
predominantly falls in two jackpot populations (100% colocalized and 0% colocalized) with a 
spread of cells in between the two main populations (Fig. 4-2C). Potentially, these cells with a 
higher percent of YopD colocalization may be responsible for inflammasome activation.  
 
Gbps contribute to inflammasome activation by Yersinia’s T3SS 
As YopD can colocalize with lysosomes and Gbps have been demonstrated to help lyse 
lysosomes and recognize cytosolic LPS that would be released from lysosomes during non-
canonical inflammasome activation (Meunier et al., 2014, Pilla et al., 2014, Finethy et al., 2015), 
we tested whether the Gbps found on chromosome 3 contributed to inflammasome activation in 
response to T3SS expressing Yersinia by infecting B6 and Gbpchr3-/- BMDMs. ΔyopEJK infection 
had significantly decreased cytotoxicity and IL-1β and IL-1α secretion in Gbpchr3-/- BMDMs (Fig. 4-
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3 A-C). Importantly, the inflammasome-independent cytokine IL-6 was not affected in Gbpchr3-/- 
BMDMs (Fig. 4-3D). Caspase-1 processing was undetectable in IFNγ primed cell lysates (Fig. 4-
3E).  
 
As cell lysates from ΔyopEJK infected Gbpchr3-/- BMDMs had no detectable caspase-1 processing 
and Gbps have been found to contribute to the canonical inflammasome (Shenoy et al., 2012), 
we wanted to see if Gbps were acting in both the canonical and non-canonical inflammasome 
pathways. If Gbps were working in both pathways, formation of caspase-1 puncta should be 
significantly lower in ΔyopEJK infected Gbpchr3-/- BMDMs in comparison to Casp11-/- BMDMs. We 
used confocal microscopy to look for caspase-1 activation as signified by caspase-1 puncta in 
Casp11-/-, Gbpchr3-/-, and B6 BMDMs (Fig. 4-4A). The percent of cells with active caspase-1 was 
significantly decreased in both Casp11-/- and Gbpchr3-/- BMDMs in comparison to B6 BMDMs after 
ΔyopEJK infection (Fig. 4-3B). There was not a significant difference in the percent cells with 
active caspase-1 between Casp11-/- and Gbpchr3-/- BMDMs. In conjunction with caspase-11 being 
the predominant inflammasome activated by hyper-translocation of YopD/B, these data suggest 
that the chromosome 3 Gbps play a role in non-canonical inflammasome activation in response to 
hyper-translocation. 
 
Gbp2 colocalizes with both YopD and Yersinia 
Chromosome 3 encodes 5 different Gbps: Gbps 1, 2, 3, 5, and 7. Gbp2 was found to be involved 
in non-canonical inflammasome activation for both the destruction of lysosomes and the 
recognition of LPS in the cytosol (Meunier et al., 2014; Pilla et al., 2014). Additionally, Gbp2 was 
found to colocalize with Galectin-8, which is recruited to lysed lysosomes (Meunier et al., 2014). 
Based on this data, we hypothesized that Gbp2 could colocalize with YopD containing lysosomes 
	  
	  
67	  
and assist in inflammasome activation by potentially increasing lysosomal damage. Using 
confocal microscopy, we were able to look for recruitment of Gbp2 with translocated YopD as well 
as Yersinia (Fig. 4-5A). A percentage of the translocated YopD in the cell colocalizes with Gbp2. 
This percentage is significantly higher in ΔyopEJK infected BMDMs in comparison to ΔyopEJ 
infected BMDMs (Fig. 4-5B). Interestingly, Gbp2 colocalizes highly to ΔyopEJK Yersinia but not 
ΔyopEJ Yersinia (Fig. 4-5C). In data not shown, Gbp2 only colocalized to Yersinia that expressed 
T3SSs that were capable of translocation. This suggests that Yersinia can translocate Yops from 
inside the lysosome. Due to the limits of the microscope’s resolution, we could potentially miss 
translocated YopD that inserts back into the Yersinia containing lysosome. Additionally, Gbp2 
recruitment is dependent on Galectin-3, which is a marker of lysosomal membrane damage 
(Feeley et al., in submission). This observation suggests that Gbp2 is recruited after damage 
occurs to the lysosome. It is possible that Gbp2 recruitment leads to exacerbation of this damage. 
It is also possible that in this system, Gbp2 is not playing the main role in Gbp-dependent non-
canonical inflammasome activation.   
 
Gbp2 colocalization with YopD is insufficient for inflammasome activation 
To determine the contribution of Gbp2 colocalization with YopD to inflammasome activation, we 
examined whether colocalization of Gbp2 correlated with caspase-1 activation in ΔyopEJK 
infected BMDMs using confocal microscopy (Fig. 4-6A). As Gbps have been suggested to act as 
platforms for inflammasome assembly in both the non-canonical and canonical inflammasomes 
(Shenoy et al., 2012; Pilla et al., 2014), we checked to see if Gbp2 colocalized with caspase-1 
puncta. No Gbp2 staining colocalized with active caspase-1 puncta (Fig. 4-6A). Additionally, there 
was no difference in colocalization of Gbp2 to YopD in cells that contained active caspase-1 in 
comparison to cells that did not contain active caspase-1 (Fig. 4-6B). These data suggest that 
Gbp2 is not the main Gbp responsible for inflammasome activation in response to Yersinia 
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infection. While Meunier and colleagues (2014) observed Gbp2 functioning as the main player in 
non-canonical inflammasome activation in response to vacuolar gram-negative bacterial infection, 
other Gbps also contributed to the observed non-canonical inflammasome activation. Additionally, 
individual shRNA knockdown of Gbp-1, Gbp2, Gbp-3, and Gbp-5 all significantly decreased non-
canonical inflammasome activation in response to cytosolic LPS (Pilla et al., 2014). As Gbpchr3-/- 
has such a large effect on inflammasome activation in response to Yersinia, we hypothesize that 
multiple Gbps each contribute partially to inflammasome activation. Alternatively, it is possible 
that a single Gbp on chromosome 3 is responsible for most of the non-canonical inflammasome 
activation.  
 
Discussion: 
Common bacterial virulence factors like specialized secretion systems and pore-forming toxins 
play important roles in establishing infection. Many bacteria employ various strategies to hide 
these key virulence factors from host immune detection. In the absence of the evasion strategies 
of the bacteria, the immune pathways activated through recognition of the virulence factor leads 
to clearance or decreased severity of the infection. By understanding which pathway is activated, 
to what extent the pathway is activated, and the precise mechanism used to activate the pathway, 
therapeutic agents can be developed that will allow for precise activation of that pathway even 
when the bacteria employ evasion strategies. Yersinia, which expresses a T3SS, inhibits 
inflammasome activation through translocation of YopK, YopM, and YopJ (Brodsky et al. 2010; 
Chung et al., 2014; LaRock and Cookson, 2012; Schoberle et al., 2016). It has been 
demonstrated that in the absence of YopK in vivo Yersinia infection is highly attenuated (Brodsky 
et al., 2010; Holmstrom et al., 1995; Najdenski et al., 2003; Straley and Cibull, 1989). This 
attenuation depends on caspase-1/11 activity (Brodsky et al., 2010). We have recently 
demonstrated that hyper-translocation of YopD and YopB was required for inflammasome 
activation in response to Yersinia infection (Zwack et al., 2015). However, the downstream 
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mechanism(s) remained unclear. Here we demonstrate that Yersinia infection activates 
predominantly the non-canonical inflammasome but also activates the canonical inflammasome 
(Figure 4-1; Casson et al., 2013). Currently only one known stimuli, intracellular LPS, has been 
demonstrated to activate the non-canonical inflammasome (Hagar et al. 2013; Kayagaki et al., 
2013; Shi et al. 2014). By determining how Yersinia hyper-translocation of YopD and YopB result 
in non-canonical inflammasome activation, we can reveal basic biology of the non-canonical 
inflammasome. Additionally, translocation of YopD and YopB represents a class of virulence 
activities in which membrane active proteins of pathogens are delivered into the host cytosol. The 
mechanism by which translocated YopD and YopB interact with and are recognized by the host 
may elucidate broadly applicable features and rules about this class of virulence factors.  
 
Lysosomal damage has been shown to play a role in both the canonical and non-canonical 
inflammasome (Hornung et al., 2008; Meunier et al., 2014). Here we demonstrate that 
translocated YopD can associate with Lamp1 containing lysosomes (Fig. 4-2) and that Gbp2 is 
recruited to both translocated YopD and Yersinia (Fig. 4-5). This suggests that YopD is causing 
damage to these lysosomes because recruitment of Gbp2 is dependent on the presence of 
Galectin-3, a known marker of lysosomal damage (Feeley et al., in submission; Paz et al., 2010). 
While Gbp2 recruitment does not correlate with caspase-1 activation during Yersinia infection 
(Fig. 4-6), knocking out all five of the Gbps on chromosome 3 significantly reduces inflammasome 
activation in response to Yersinia infection (Fig. 4-3). Interestingly, the degree of reduction in 
inflammasome activation in response to Yersinia is similar to caspase-11 deficiency (Fig. 4-4). 
Combined these data suggest that at least one Gbp found on chromosome three is important for 
non-canonical inflammasome activation during Yersinia infection. Our data suggest that Gbp2 is 
not the major Gbp involved in non-canonical inflammasome activation in response to hyper-
translocation of YopD and YopB. However, we cannot discount that the Gbps are working in 
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combination and that Gbp2 could play a role in conjunction with one or more of the other Gbps 
found on chromosome 3.  
As these data suggest that translocated YopD causes lysosomal damage to both Yersinia 
containing and Yersinia free lysosomes (Fig. 4-5), it is possible that release of a bacterial product 
from a Yersinia containing lysosome is responsible for activating the non-canonical 
inflammasome. While LPS from Yersinia pestis grown at 37 °C does not activate caspase-11, it is 
unknown whether LPS from Yersinia pseudotuberculosis grown at 37 °C can activate the non-
canonical inflammasome. It was previously demonstrated that LPS from 37 °C grown Yersinia 
pseudotuberculosis can stimulate TLR4 but the stimulation is drastically weaker than LPS from 21 
°C grown Yersinia pseudotuberculosis (Rebeil et al., 2004). To date, the non-canonical 
inflammasome seems to be stimulated by various LPS species similarly to how TLR4 is. Further 
experiments are needed to determine whether it is release of LPS or a different bacterial product 
that is important for non-canonical inflammasome activation by Yersinia. 
 
Although YopD can associate with the lysosome, it is possible that activation of the 
inflammasome is separate from this association. As work by the Coers lab has demonstrated that 
Gbps can act in the cytosol to aid in activation of the non-canonical inflammasome (Finethy et al., 
2015; Pilla et al., 2014), it is possible that the translocated YopD and YopB superstructures, 
which we previously reported (Zwack et al., 2015), may be separate from membranes and 
interact with Gbps in the cytosol. In the case of hexa-acylated LPS, activation of the non-
canonical inflammasome occurs through direct binding of LPS to caspase-11. Interestingly, SipB, 
a translocon protein of the Salmonella SPI-1 T3SS, was initially found to bind to caspase-1. 
Because caspase-11 is closely related to caspase-1 and YopB is similar to SipB, these YopB and 
YopD superstructures could potentially interact directly with caspase-11. Further experiments are 
required to determine these interactions. The work described in this chapter provides a strong 
foundation for dissecting the complex mechanism by which Yersinia activates the non-canonical 
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inflammasome. The structure of T3SSs is highly conserved. Here we have identified players 
involved in the recognition of T3SS expressing Yersinia. These components possibly represent 
both a broader mechanism for recognizing T3SS expressing bacteria and points in the pathway 
that the bacteria potentially target to prevent recognition.    
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Figure 4-1: Yersinia infection primarily activates the non-canonical inflammasome.  
A. B6, Casp1-/-, Casp11-/-, and Casp1Casp11-/- BMDMs were infected with indicated  
Yersinia strains or treated with LPS or LPS + ATP. Cytotoxicity was determined by LDH  
release. Graph is representative of three independent experiments. *p < 0.05.  
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B-C. Supernatants from B6, Casp1-/-, Casp11-/-, and Casp-1Casp11-/- BMDMs infected 
with indicated bacterial strains or treated with LPS or LPS + ATP were assayed for levels of  
secreted IL-1β and IL-1α by ELISA as described in materials and methods. 
Graph is representative of three independent experiments.*p < 0.05.  
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Figure 4-2: Translocated YopD colocalizes with Lamp1 containing lysosomes. A. Single z-
stacks of confocal microscopy images of BMDMs that were pretreated with YVAD and left 
uninfected or infected with ΔyopEJK or ΔyopEJ for 2 hrs. Cells were stained for YopD (green), 
Yersinia (red), and Lamp1 (blue). White outlines represent cells as determined by CellMask blue 
staining. White scale bar represents 10 µm. B. Volume of YopD colocalized with Lamp1 (µm3) in 
ΔyopEJK and ΔyopEJ. Each dot represents a single cell. C. Percent of total translocated YopD 
colocalized with Lamp1 in ΔyopEJK and ΔyopEJ. Each dot represents a single cell. Graphs 
representative of 2 independent experiments. 
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Figure 4-3: Guanylate Binding Proteins are important for Yersinia activation of the  
inflammasome. A. B6 and Gbpchr3-/- BMDMs were infected with indicated Yersinia strains or  
Salmonella or treated with LPS. Cytotoxicity was determined by LDH release. Graph is  
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representative of three independent experiments. *p < 0.05. B-D. Supernatants from B6 and  
Gbpchr3-/- BMDMs infected with indicated bacterial strains or treated with LPS were assayed  
for levels of secreted IL-1β, IL-1α, and IL-6 by ELISA as described in materials and methods. 
Graph is representative of three independent experiments.*p < 0.05. E. B6 and Gbpchr3-/- 
BMDMs infected with indicated bacterial strains. Cell lysates were assayed for  
pro- and processed caspase-1 and actin as indicated. 
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Figure 4-4: Guanylate binding proteins are involved in Yersinia activation of the non-
canonical inflammasome. A. Collapsed z-stacks of confocal microscopy images of B6,   
Casp11-/-, and Gbpchr3-/- BMDMs that were pretreated with YVAD and infected with ΔyopEJK for 2 
hrs. Cells were stained for YopD (green) and caspase-1 p10 (red). White outlines represent cells 
as determined by CellMask blue staining. White scale bar represents 10 µm. B. Percent of total 
cells that are caspase-1 puncta positive. Each dot is representative of a single field. Data are 
pooled from 3 independent experiments.  *** p < 0.0005. **** p<0.0001. 
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Figure 4-5: Translocated YopD colocalizes with Gbp2. A. Single z-stacks of confocal 
microscopy images of BMDMs that were pretreated with YVAD and left uninfected or infected 
with ΔyopEJK or ΔyopEJ for 2 hrs. Cells were stained for YopD (blue), Yersinia (red), and Gbp2 
(green). White outlines represent cells as determined by CellMask blue staining. White scale bar 
represents 10 µm. B. % of total translocated YopD that colocalizes with Gbp2 in ΔyopEJK and 
ΔyopEJ. Each dot represents a single cell. C. Percent of total Gbp2 that colocalizes with Yersinia 
in ΔyopEJK and ΔyopEJ. Each dot represents a single cell. 
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Figure 4-6: Caspase-1 activation does not correlate with colocalization of Gbp2 with YopD. 
A. Single z-stacks of confocal microscopy images of BMDMs were left uninfected or infected with 
ΔyopEJK for 2 hrs. One hour post-infection FAM-FLICA (green) was added to detect active 
caspase-1. Cells were stained for YopD (blue), Gbp2 (red). White outlines represent cells as 
determined by CellMask blue staining. White scale bar represents 10 µm.  B. Volume of YopD 
colocalized with Gbp2 (µm3) in caspase-1 puncta positive and puncta negative cells. Each dot 
represents a single cell. C. Percent of total YopD colocalized with Gbp2 in caspase-1 puncta 
positive and puncta negative cells. Each dot represents a single cell. Graphs representative of 2 
independent experiments. 
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CHAPTER 5 
A role for YopK and balance of translocation in evading innate immune responses 
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Abstract: 
Inflammasome mediated immune responses play a vital role in clearance of Yersinia. Recognition 
of Yersinia by the inflammasome requires expression of the T3SS. Because Yersinia requires 
translocation of effectors by the T3SS to establish infection in mammals, Yersinia acquired 
multiple mechanisms to avoid activation of the inflammasome. YopK was the first effector 
identified to prevent inflammasome activation during Yersinia infection, but how YopK prevents 
inflammasome activation remains unclear. As hyper-translocation of YopD and YopB are required 
for inflammasome activation, we tested whether mutations in YopK that allowed for increased 
translocation fail to prevent inflammasome activation. We determined that these mutants both fail 
to prevent inflammasome activation and are attenuated in vivo. To determine if YopK functions by 
preventing translocation of YopD/B, we expressed LcrHmut1, a mutated chaperone protein for 
YopB/D, in both WT and YopK-deficient Yersinia. Intriguingly, instead of having restored 
virulence, infections with these strains were fully attenuated. We determined that the presence of 
all the Yops combines with LcrHmut1 to generate a larger effect on translocation. Interestingly, 
deletion of YopK restored the level of translocation of both YopJ and YopM but not YopE. These 
data suggest that different effectors have more stringent requirements for proper translocation. 
Understanding the fundamental nature of the T3SS and the mechanisms which prevent immune 
recognition of the T3SS provide a strong foundation for finding therapeutics that help the immune 
system combat T3SS expressing bacteria.    
 
Introduction:	  
Innate immune responses play critical roles in pathogen clearance. Combinations of surface and 
endosomal receptors like the TLRs and intracellular receptors such as the NLRs recognize 
conserved virulence structures and activities to generate an effective response to the pathogen 
(Janeway and Medzhitov, 2002; Vance et al., 2009). These responses include recruitment of 
neutrophils, activation of macrophages and dendritic cells, T cell activation, and many others 
(Chow et al., 2016; Lee et al., 2015; He et al., 2008; Lukens et al., 2012; Kupz et al., 2012). As 
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the structures and activities recognized by the immune system are often essential to the ability of 
the pathogen to survive in its host, pathogens have adapted ways to interfere with both the initial 
recognition and the downstream responses.  
 
Yersinia requires expression of its T3SS and effectors in order to infect mammalian hosts. 
However, expression of the T3SS leads to activation of the inflammasome in part because of 
hyper-translocation of the pore proteins YopD and YopB (Zwack et al., 2015). Yersinia employs 
multiple mechanisms to prevent inflammasome activation. The effector YopM sequesters 
caspase-1 thus preventing its recruitment to the inflammasome (Chung et al., 2014; LaRock and 
Cookson, 2012). It has recently been found that YopJ also contributes to the inhibition of the 
inflammasome in primed macrophages although the mechanism remains unknown (Schoberle et 
al., 2016). YopK was the first effector identified to inhibit inflammasome activation but the 
mechanism remains unknown (Brodsky et al., 2010). Prior to determining that YopK inhibits the 
inflammasome, YopK was described to both decrease the size of the translocon pore and 
negatively regulate the translocation of other effectors into the cell (Holmstrom et al., 1997). 
Based on the previous observation that inflammasome activation in response to Yersinia requires 
hyper-translocation of YopD and YopB (Zwack et al., 2015), we hypothesize that YopK inhibits 
inflammasome activation by negatively regulating translocation of YopD and YopB. We further 
considered that preventing YopD and YopB translocation by alternative methods could 
complement YopK deletion. Here we define mutations in YopK that fail to inhibit inflammasome 
activation. Our data further demonstrates that Yersinia’s T3SS and effectors make a balanced 
system. Small changes to optimize one portion of the system can cause clearance of the bacteria 
by altering regulation of another effector.    
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Results:  
YopK mutations that allow for increased translocation fail to prevent 
inflammasome activation 
Thorslund and colleagues (2011) performed an alanine substitution screen spanning the full 
length of YopK. A query of these mutations by yeast two-hybrid indicated that RACK1 interacted 
with all YopK mutations except when the threonine and aspartic acid were substituted with 
alanines at position 45 and 46, respectively (Thorslund et al., 2011). Additionally they determined 
that this mutation conferred increased translocation in comparison to wild-type YopK. We 
hypothesized that interaction between YopK and RACK1 mediated translocation and that the 
regulation of translocation prevented inflammasome activation. In order to test whether interaction 
with RACK1 and the negative regulation of translocation was necessary for YopK inhibition of the 
inflammasome, we generated control mutations that interacted with RACK1 by yeast two-hybrid 
that were distal (SK28-29AA) or adjacent (LR43-44AA) to the mutation identified by Thorslund as 
well as the identified mutation (TD45-46AA)(Fig. 5-1A).  As described previously, YopKTD45-46AA 
had increased translocation in comparison to wild-type YopK (Fig. 5-1B). Interestingly, while the 
control mutation YopKSK28-29AA allowed for translocation of YopE similarly to WT YopK, YopKLR43-
44AA conferred significantly higher translocation in comparison to WT YopK (Fig. 5-1B). This data 
initially suggested that RACK1 was not required for regulation of translocation by YopK. Work by 
Dewoody and colleagues (2013) showed that YopKTD45-46AA was able to interact with RACK1 by 
using immunoprecipitation, thus further supporting that YopK mediates translocation 
independently of RACK1. 
 
Although RACK1 does not seem necessary for YopK regulation of translocation, we still 
hypothesize that YopK regulation of translocation is required to prevent inflammasome activation.  
Using our YopK mutants that allow for increased translocation as well as our mutant that confers 
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normal regulation of translocation, we infected B6 BMDMs to determine if mutants that fail to 
regulate translocation allow for inflammasome activation. Yersinia expressing either YopKLR43-44AA 
or YopKTD45-46AA failed to prevent cell death, and IL-1β and IL-1α secretion (Fig. 5-1 C-E). Both 
mutations functioned like the full deletion. Conversely, Yersinia expressing either WT YopK or 
YopKSK28-29AA drastically decreased both cell death, and IL-1β and IL-1α secretion in comparison 
to full YopK deletion. As mutants that allowed for increased translocation activated the 
inflammasome and it has been demonstrated that inflammasome activation plays a key role in 
clearance of Yersinia that lack YopK (Fig. 5-1B; Brodsky et al., 2010), we next examined whether 
Yersinia expressing YopKLR43-44AA would be attenuated in vivo. B6 mice infected by intraperitoneal 
(i.p.) injection with YopKLR43-44AA had a lower bacterial burden in the spleen in comparison to WT 
and YopKSK28-29AA (Fig. 5-1F). Our data on these YopK mutations in combination with our previous 
observation that hyper-translocation of YopD and YopB is required for inflammasome activation 
support a model where YopK limits inflammasome activation by negatively regulating the 
translocation of YopD and YopB. 
	  
LcrH point mutants fully attenuate Yersinia infection in vivo 
We previously demonstrated that certain point mutations in LcrH, the chaperone protein for both 
YopD and YopB, prevented the translocation of YopD and YopB while allowing for the 
translocation of other effectors when expressed in a ΔyopEJK background strain (Zwack et al., 
2015). To test whether preventing translocation of YopD and YopB would restore virulence during 
in vivo infection by a ΔyopK strain of Yersinia, we generated the LcrH point mutant lcrHmut1 in 
both WT and ΔyopK strains of Yersinia. Infection with either WT-lcrHmut1 or ΔyopK-lcrHmut1 
resulted in complete attenuation of the infection instead of enhanced virulence (Fig. 5-2 and data 
not shown). Interestingly, the bacterial burden observed phenocopied burdens observed when 
mice were infected with ΔyopBD Yersinia, which fail to make a functional T3SS as they lack the 
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translocon proteins (Fig. 5-2). This observation lead us to the hypothesis that interactions among 
the full complement of effectors and LcrH mutants affect translocation differently than the 
interactions among LcrH mutants and the effectors in the absence of YopE and YopJ. 
 
In both the presence and absence of YopK, LcrH point mutants fail to properly 
translocate YopE  
We next examined the effect of background strain on the translocation phenotype of our lcrH 
mutant. It has been demonstrated that YopE negatively regulates translocation of the Yops. YopE 
potentially induces this phenomenon by affecting actin cytoskeleton near the pore complex (Mejia 
et al., 2008). As WT-lcrHmut1 Yersinia express YopE, interactions between YopE activity and the 
translocon could result in reduced translocation that would not be seen with YopE-deficient 
strains.  As previously demonstrated, ΔyopEJK-lcrHmut1 translocated normally YopE and YopM 
(Fig. 5-3). WT-lcrHmut1 had decreased translocation of YopE, YopM, and YopJ in comparison to 
WT and ΔyopK.  Intriguingly, ΔyopK-lcrHmut1 allowed for translocation of YopM and YopJ at 
normal levels but failed to return YopE translocation to normal levels (Fig. 5-3). YopE inhibits 
actin rearrangement and plays a crucial role in both preventing neutrophil oxidative burst and 
phagocytosis (Grosdent et al., 2002; Songsungthong et al., 2010). While deletion of YopE has 
been demonstrated to cause partial attenuation in vivo, YopE deletion does not result in complete 
clearance (Songsungthong et al., 2010). Therefore, it is probable that another effector Yop’s 
translocation is affected by the mutations in LcrH in the presence of YopE. The T3SS has no 
easily defined signal sequence that is common to its effectors. The differential effect of LcrHmut1 
on effector translocation could reveal interesting information about translocation hierarchy and 
effector-T3SS apparatus interactions.   
 
	  
	  
90	  
Discussion: 
The human pathogenic Yersiniae require a T3SS and its associated effectors to cause a 
productive infection in mammalian hosts. These effectors target host cell processes that would 
otherwise aid in the clearance of Yersinia. YopJ targets NFκB and MAPK signaling to prevent up-
regulation of cytokines and possibly aids in bypassing the gut barrier (Monack et al., 1997; 
Palmer et al., 1998). YopE inhibits actin rearrangement, which prevents both neutrophil oxidative 
burst and phagocytosis (Grosdent et al., 2002; Songsungthong et al., 2010). Yops H, O, and T 
also target cellular components important for phagocytosis (Grosdent et al., 2002). By targeting 
these innate immune defenses, Yersinia can survive in mammalian hosts. Incidentally, the 
machinery needed to deliver these effectors into the cell provides an excellent target for immune 
recognition. Hyper-translocation of the T3SS translocon proteins YopD and YopB leads to 
activation of the inflammasome (Zwack et al., 2015). In order to balance the necessity of 
translocating the effectors with the inevitability of translocating the translocon components, 
Yersinia evolved effectors that prevent activation of the inflammasome in response to infection by 
T3SS expressing Yersinia. Interestingly, both YopM and YopK, effectors that prevent 
inflammasome activation, do not use enzymatic activity to inhibit inflammasome activation. YopM 
either directly sequesters caspase-1 or indirectly acts on the inflammasome through IQGAP1 
depending on the strain of Yersinia (Chung et al., 2014; LaRock and Cookson, 2012). The 
mechanism by which YopK inhibits the inflammasome has been somewhat elusive. 
 
 
Here we demonstrate that mutations in YopK that decrease its ability to negatively regulate 
translocation also prevent inhibition of the inflammasome (Fig. 5-1A-E). These mutations are 
located immediately adjacent to each other and replace charged residues (Fig. 5-1A). It has been 
demonstrated that it is the change of the aspartic acid to an alanine and not the threonine to 
alanine substitution that abrogates YopK’s ability to regulate translocation (Dewoody et al., 2013). 
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Based on these data, we hypothesize that this region plays an important part in the interactions 
between YopK and other proteins needed to negatively regulate translocation. 
 
 
In the process of trying to determine how YopK inhibits inflammasome activation, we have also 
uncovered some basic information on how the components of the T3SS and its effectors interact. 
LcrHmut1 has previously been demonstrated to have a decreased ability to lyse red blood cells 
(Edqvist et al., 2007). This indicates that either the size or number of translocons produced by 
Yersinia is reduced. In the absence of fully functional YopE, translocation of effectors occurs at 
normal levels by Yersinia expressing LcrHmut1 (Fig. 5-3A-B, Zwack et al., 2015). As YopE’s 
ability to inhibit actin rearrangement has been implicated in the negative regulation of 
translocation, it is possible that the absence of YopE allows for a more optimal configuration of 
the translocon in the host membrane. Thus, translocation occurs at a similar level to WT Yersinia 
even though the translocons are either smaller in size or fewer in number. In the presence of all 
the effectors, translocation of YopJ, YopM, and YopE is decreased when Yersinia express 
LcrHmut1 (Fig. 5-3). The combination of YopE’s effect on the actin cytoskeleton (Mejia et al. 
2008), YopK’s dual functions of decreasing pore size and negatively regulating translocation 
(Holmstrom et al., 1997), and LcrHmut1’s effect on translocons could act in concert to decrease 
the efficiency of effectors leaving the T3SS by reducing the size of the pore (Edqvist et al. 2007). 
In the absence of YopK, expression of LcrHmut1 in the presence of YopE does not affect the 
ability of the T3SS to translocate YopJ and YopM (Fig 5-3B-C). Intriguingly, the absence of YopK 
does not restore YopE translocation to normal levels (Fig. 5-3A). As deletion of YopE alone does 
not result in complete clearance of Yersinia in vivo (Songsungthong et al., 2010), YopH or 
possibly YopO translocation is likely similar to what we observe with YopE. YopE is the smallest 
of the three effectors that we tested for translocation; therefore, it is unlikely that pore size is 
responsible for the reduction in YopE translocation by ΔyopK-lcrHmut1. Instead, these data 
suggest that different Yops are more sensitive to the translocon pore configuration. Initial low-
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level translocation of YopE could induce a conformation change in the translocon that could 
expose or hide different residues necessary for further YopE translocation. As failure of YopE to 
pass through the translocon should block other Yops from exiting the T3SS, this model suggests 
a hierarchy of effector translocation where YopM and YopJ are translocated prior to YopE. 
Another possibility is that sufficient T3SSs are produced by the bacteria that enough T3SSs are 
available to translocate the other Yops even if some are blocked by YopE.  While translocation of 
YopE may be regulated by the conformation of the translocon, it is possible that interactions in 
the bacteria between YopE and either the translocon proteins or LcrH regulate YopE 
translocation. In the presence of endogenous YopE, the YopE-β-lactamase reporter may be 
competing for a limited supply of YopD or YopB. This competition could result in decreased 
translocation of the reporter construct. To test whether translocation of YopE is dependent on the 
conformation of the translocon or an interaction within the bacteria, we will use antibodies against 
YopE to look for translocation of endogenous YopE. Our findings enhance our current 
understanding of an important virulence structure of pathogens.   
 
 
While the human immune system has evolved effective ways to identify and respond to 
pathogens, pathogens continue to evolve ways to circumvent these defenses. By understanding 
the mechanisms that pathogens use to bypass our defenses, we can develop therapeutic 
strategies that reactivate that arm of defense. The T3SS is an obvious target for immune 
recognition of many gram-negative bacteria. Yersinia employs multiple strategies to shut down 
activation of the inflammasome in response to infection with T3SS expressing Yersinia. There is 
no sequence homolog to YopK. Work done here and by others to determine how YopK functions 
and inhibits inflammasome activation will allow us to not only find ways to bypass YopK’s 
inhibition of the inflammasome but also determine if there are functional homologs or other 
changes in different gram-negative bacteria that control accidental recognition of the pore 
proteins. Additionally, the new insights provided here on the balance maintained by the T3SS and 
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its effectors to allow for function could offer potential targets for destabilizing the T3SS. Acquiring 
a fundamental understanding of the virulence structures and effectors of pathogens provides us 
with the necessary foundation to develop new treatments in this age of multi-drug resistance.    
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Figure 5-1: YopK mutants that allow for increased translocation fail to prevent 
inflammasome activation. A. Schematic of three mutations generated in YopK. B. HeLa cells 
were infected with indicated strains expressing a YopE-β-lactamase fusion protein (YopE-Bla). 
Cells were loaded with CCF4-AM dye and ratio of blue:green signal (translocation) was 
calculated as described in materials and methods. Representative of 3 independent experiments. 
C. BMDMs were infected with ΔyopHOJMEK expressing either an empty vector, WT YopK, or the 
indicated YopK mutants or treated with LPS + ATP. Cytotoxicity was determined by LDH release. 
Graph is representative of three independent experiments.	  *p < 0.05. E-F. Supernatants from 
BMDMs infected with indicated bacterial strains were assayed for levels of secreted IL-1β and IL-
6 by ELISA as described in materials and methods. Graph is representative of three independent 
experiments.	  *p < 0.05. G. Mice were infected with indicated Yersinia strain by i.p. injection. 
Spleens were harvested and homogenized day 4 post infection. Homogenates were plated on LB 
irgasan plates. Colonies were counted and CFU/g spleen was calculated. *p < 0.05.  
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Figure 5-2: Yersinia expressing LcrH point mutants are attenuated in vivo. A. Spleens and 
B. Livers were harvested and homogenized day 3 post i.p. infection. Homogenates were plated 
on LB irgasan plates. Colonies were counted and CFU/g spleen was calculated. * p < 0.05. 
Dashed line indicates limit of detection. The graph is representative of 3 independent 
experiments. 
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Figure 5-3: LcrHmut1 affects translocation of Yops in the presence of all the effectors. 
HeLa cells were infected with indicated strains expressing A. YopE-β-lactamase fusion protein, B. 
YopM-β-lactamase fusion protein, or C. YopJ-β-lactamase fusion protein. Cells were loaded with 
CCF4-AM dye and ratio of blue:green signal (translocation) was calculated as described in 
materials and methods. * p < 0.05.  The graph is representative of 3 independent experiments. 
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Table 5-1. Yersinia strains used in this study 
 
Strain Name Relevant Characteristics Reference or Source 
Y. pseudotuberculosis 
IP2666 (WT) 
 
ΔyopB 
 
Wild-type 0:3 strain 
 
Full deletion of translocon 
protein YopB on IP2666 
background 
 
Black and Bliska, 1997 
 
Palmer et al., 1998 
 
ΔyopK 
 
Full deletion of YopK on 
IP2666 background 
 
 
Brodsky et al., 2010 
 
 
ΔyopEJK 
 
Full deletion of Yops E, J, 
and K on IP2666 
background 
 
 
Zwack et al., 2015 
 
ΔyopHOJMEK Full deletion of Yops H, 
O, J, M, E, and K on 
IP2666 background 
 
Lilo et al., 2008 
pyopK YopK expressed on 
plasmid PACYC184 
 
Brodsky et al., 2010 
pSK28-29AA yopK YopK expressed on 
plasmid PACYC184 
encoding the amino acid 
mutation SK28-29AA 
 
This work 
pLR43-44AA yopK YopK expressed on 
plasmid PACYC184 
encoding the amino acid 
mutation LR43-44AA 
 
This work 
pTD45-46AA yopK YopK expressed on 
plasmid PACYC184 
encoding the amino acid 
mutation TD45-46AA 
 
Thorslund et al., 2011 
This work 
ΔyopBD Full deletion of translocon 
proteins YopB and YopD 
on IP2666 background 
Zwack et al., 2015 
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lcrHmut1 
 
LcrHY40C, I101M, K102R  
 
Edqvist et al., 2007,  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
	  
100	  
CHAPTER 6 
DISCUSSION 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
101	  
In the work presented in this dissertation, I dissected mechanisms through which the T3SS of 
Yersinia activates the inflammasome. I demonstrated that hyper-translocation of the pore proteins 
YopD and YopB is required for inflammasome activation in response to the Yersinia T3SS. I also 
showed that this hyper-translocation leads mainly to non-canonical inflammasome activation 
through a process requiring guanylate binding proteins (Gbps) from chromosome 3. Furthermore, 
our data demonstrate that translocated YopD traffics to lysosomes and is associated with 
lysosomal damage. Our work also revealed new insights into how YopK, an effector protein that 
prevents inflammasome activation, functions to exert this activity.  
 
A. Internal delivery of pore-forming proteins are a trigger for innate immune 
responses  
In this study, we determined the necessary functions of the Yersinia T3SS for activation of the 
inflammasome. Earlier studies had determined that in the presence of LPS priming or the 
absence of YopK, Yersinia infection leads to inflammasome activation (Bergsbaken and 
Cookson, 2007; Brodsky et al., 2010); however, it remained unclear how the inflammasome was 
activated. As external delivery of pore-forming proteins such as α-hemolysin and listeriolysin O 
(LLO) activates the inflammasome (Craven et al., 2009; Meixenberger et al., 2010) and 
effectorless strains of Yersinia activate the inflammasome (Brodsky et al., 2010), we initially 
hypothesized that pore-formation caused by insertion of the T3SS translocon into the plasma 
membrane triggered the inflammasome. Surprisingly, analysis of a series of YopD mutants that 
separate pore-formation from translocation demonstrated that pore-formation caused by the 
translocon pore was insufficient to trigger inflammasome activation (Fig. 3-1). These data show 
that translocation is required to activate the inflammasome.  As none of the six Yersinia effectors 
are needed for inflammasome activation, we investigated whether the translocon pore proteins 
YopD and YopB activated the inflammasome. While the T3SS can translocate YopB and YopD 
(Francis and Wolf-Watz, 1998; Dewoody et al., 2013), the effects of this translocation were 
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unknown. We determined that translocation of YopD/B correlated with activation of caspase-1 
(Fig. 3-3 and Fig. 3-4). However, this result suggested two possible models for inflammasome 
activation: 1. translocation of YopD and YopB leads to activation of the inflammasome; or 2. 
translocation of YopD and YopB act as a surrogate reporter for the translocation of an unknown 
molecule, which activates the inflammasome. In order to test the hypothesis that translocation of 
YopD/B leads to inflammasome activation, we used mutants in the chaperone protein of YopD 
and YopB, which allowed for translocation of everything but YopD and YopB. Intriguingly, we 
observed that the specific hyper-translocation of YopD and YopB is the key signal for 
inflammasome activation (Fig. 3-4, Fig. 3-5, and Fig. 3-6).  
 
YopD, a single pass transmembrane protein, and YopB, a double pass transmembrane protein, 
make up the translocon pore complex of the Yersinia T3SS along with the platform protein LcrV 
(Cornelis and Wolf-Watz, 1997; Hakansson et al., 1993). In the presence of YopK, Yersinia limits 
intracellular delivery of these proteins (Fig. 3-3D-E and Dewoody 2013), suggesting that YopK 
acts to inhibit inflammasome activation by negatively regulating the translocation of the pore 
proteins into the host cell. In the case of Yersinia, hyper-translocation of YopD and YopB lead to 
activation of the inflammasome by both the canonical and non-canonical inflammasome (Fig. 4-1) 
although the exact mechanism of inflammasome activation by hyper-translocation of the pore 
proteins is not fully defined. 
 Internally delivered pore proteins such as YopD and YopB are a general feature of bacterial 
pathogens that utilize T3SS (Dewoody et al., 2013; Francis and Wolf-Watz, 1998; Hersh et al. 
1999). This is likely due to the mechanics of how the T3SS functions, as the translocon proteins 
themselves are secreted through the needle complex, and must assemble at the needle tip in 
order to generate a functional pore. The Salmonella homolog of YopB, known as SipB, is also 
injected by Salmonella into host cells, and initial studies describing activation of caspase-1 in 
response to Salmonella found that microinjection of SipB caused caspase-1 dependent cell death 
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(Hersh et al., 1999). Additionally, caspase-1 was co-immunoprecipitated from cells infected with 
Shigella expressing plasmid encoded SipB. These data demonstrated that SipB can associate 
with caspase-1 (Hersh et al., 1999). These observations suggest the potential for pore proteins to 
directly bind and possibly activate caspases (Fig. 6-1).  In addition to the delivery of pore proteins 
into the cytosol by bacteria expressing T3SSs, many other pathogens employ virulence strategies 
that result in pore proteins being delivered or expressed inside the host cell. The internal delivery 
of these pore proteins often lead to insertion of the proteins into cytosolic membrane bound 
structures (Fig. 6-1). During influenza infection, the channel protein M2 inserts into the Golgi 
apparatus causing H+ ion flux, the neutralization of the Trans Golgi Network, and the activation of 
the NLRP3 inflammasome (Ichinohe et al., 2010). The gram-positive bacteria Listeria express the 
cytolysin LLO when inside a host cell phagosome, allowing the Listeria to escape the vacuole 
(Moors et al., 1999). LLO expression is required for activation of both the NLRP3 inflammasome 
by disruption of the lysosome and the AIM2 inflammasome activation by releasing DNA from the 
lysosome into the cytosol (Kim et al., 2010). Similarly, release of pneumolysin from dying 
Streptococcus pneumoniae in the lysosome results in activation of both the AIM2 and NLRP3 
inflammasomes (Fang et al., 2011). Interestingly, Leukocidin A/B (LukAB) of Staphylococcus 
aureus results in NLRP3-mediated cell death when inserted into the plasma membrane but 
triggers NLRP3-independent cell death with NLRP3-dependent caspase-1 activation and IL-1β 
secretion when delivered intracellularly (Melehani et al., 2015). Together these findings imply that 
host cells recognize disruption of normal functions by the insertion of pores into internal 
membrane structures as a feature of pathogenesis. Depending on the infection, intracellular 
delivery of pore proteins can either be an unintended consequence of or an important mechanism 
for establishing infection. No matter the reason for the presence of the pore protein inside the cell, 
intracellular pore-forming toxins are inherently foreign to the cytosol and always run the risk of 
damaging the cell. These features of pore-forming toxins make them ideal targets for intracellular 
immune recognition. Internal delivery of pore-forming proteins by pathogens allows for indirect 
activation of inflammasomes by damaging internal organelles as well as releasing bacterial 
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products from lysosomes and potentially allows for direct activation of caspases through binding 
by pore proteins.   
 
Figure 6-1: Schematic innate immune responses activated by internally delivered pore 
proteins. Bacterial and viral pore proteins can insert into a variety of internal membrane 
structures. Pore proteins can also interact with proteins in the cytosol.  
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Internal delivery of pore-forming proteins provides signals capable of activating multiple innate 
immune pathways. These proteins are spread across not just different bacterial species but 
different varieties of pathogens.  As a result, they vary in sequence, which can make it difficult for 
direct recognition by one sensor. By recognizing the effects of virulence activities on the cell, the 
host cell can recognize classes of pathogenesis indicators that are employed by a broad range of 
pathogens. Additionally, the recognition of the activity of the proteins allows for both redundant 
and tunable responses. For example, many internally delivered pore-proteins damage lysosomes 
and release both lysosomal host contents and bacterial products. Release of host lysosomal 
contents leads to the activation of NLRP3, release of bacterial and viral DNA lead to AIM2 
activation, and release of hexa-acylated LPS leads to non-canonical inflammasome activation 
(Fernandes-Alnemri et al., 2009; Hagar et al., 2013; Hornung et al., 2008; Kayagaki et al., 2013). 
In the case of the Yersinia proteins YopD/B, hyper-translocation leads to both canonical and non-
canonical inflammasome activation (Fig. 4-1). These redundant mechanisms can compensate for 
evasion mechanisms instigated by pathogens such as the modification of LPS to a tetra-acylated 
form. Furthermore, recognition of downstream consequences of activities can make the response 
tunable. While certain signals elicit strong responses (flagellin in mouse model), other signals can 
be more modest. When an activity leads to multiple consequences, a cumulative effect can be 
observed and amplify the response. In the case of hyper-translocation of the Yersinia pore 
proteins, we observe both non-canonical and canonical inflammasome activation. Defining the 
mechanisms through which hyper-translocation of YopD/B activate these pathways will enhance 
our understanding of how these pathways interact to provide an optimal immune response.   
 
B. A role for Guanylate Binding Proteins in non-canonical inflammasome 
activation downstream of YopD hyper-translocation 
Interferon inducible GTPases have long been known to play roles in control of vacuolar 
pathogens. They recruit machinery such as nitric oxide synthases and autophagy proteins to 
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control these pathogens (Kim et al., 2011; MacMicking, 2012). Additionally, they can cause direct 
lysis of the lysosome leading to release of the pathogen into the cytosol as well as lysis of 
cytosolic bacteria (MacMicking, 2012). More recently a subset of these GTPases called the Gbps 
have been found to be involved in both canonical and non-canonical inflammasome activation 
(Shenoy et al., 2012; Meunier et al. 2014; Pilla et al., 2014; Finethy et al., 2015). Gbp5 can bind 
to NLRP3 and is thought to act as a platform or scaffolding protein that facilitates inflammasome 
formation (Shenoy et al., 2012). Gbps have been implicated in a number of roles in activation of 
the non-canonical inflammasome. For example, Gbps damage vacuolar integrity and allow for the 
release of LPS from the lysosome into the cytoplasmic compartment (Meunier et al., 2014). 
Additionally, it has been demonstrated that Gbps recognize cytosolic LPS independent from its 
release from the vacuole (Pilla et al., 2014). Here we demonstrated that the Gbps found on 
chromosome 3 play a critical role in inflammasome activation in response to Yersinia infection 
(Fig. 4-3 and 4-4).  
 
Mechanistically, how Gbps contribute to Yersinia-induced inflammasome activation is currently 
unknown. However, Gbps may recognize the presence of damaged lysosomal membranes, or 
themselves be responsible for amplifying T3SS-induced membrane damage. Either or both of 
these mechanisms have the potential to link Gbp function to inflammasome activation. Whether 
Gbps act upstream of initial lysosomal damage potentially depends on the signal. We determined 
that YopD can colocalize with the lysosome (Fig. 4-2). Logically, colocalization of a membrane 
active protein with a membrane bound compartment could result in damage to the membrane. 
We found that Gbp2 colocalizes with both translocated YopD and ΔyopEJK Yersinia (Fig. 4-5). In 
collaboration with the Coers lab, we determined that colocalization of Gbp2 with Yersinia requires 
translocation activity of the T3SS. As recruitment of Gbp2 to Yersinia requires Galectin-3 and 
Galectin-3 recognizes damaged lysosomes, translocation-competent Yersinia potentially are 
capable of damaging the lysosome upstream of Gbp2 recruitment (Feeley et al., in submission; 
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Paz et al., 2010). This also suggests that translocated YopD, which colocalizes with lysosomes, 
triggers lysosomal membrane damage. Alternatively, it is possible that other Gbps from 
chromosome 3 are recruited to these lysosomes first and initiate the damage recognized by 
Galectin-3. Current technical limitations make it difficult to determine the temporal kinetics or 
recruitment of the other Gbps located on chromosome 3. While Gbp2 is recruited to YopD, its 
recruitment does not correlate with caspase-1 puncta formation (Fig. 4-6). This suggests that 
Gbp2 does not play a dominant role in the activation of the non-canonical inflammasome, or at 
the very least, that recruitment of Gbp2 to lysosomes is not the functional signal leading to 
inflammasome activation. These data may suggest that a single Gbp that is not Gbp2 plays the 
dominant role, multiple Gbps are playing redundant roles, or the Gbps individually have small 
cumulative effects. Future experiments using single knockout or siRNA knockdown of the Gbps 
located on chromosome 3 will help determine the contributions of the individual Gbps necessary 
for non-canonical inflammasome activation. Because different Gbps play distinct roles in other 
innate responses to vacuolar pathogens (Kim et al., 2011), identifying the responsible Gbps will 
provide important information not only on how hyper-translocation of YopD/B is recognized but 
also on the relationship between the different innate pathways that share the Gbps.       
	  
C. Potential models of inflammasome activation by hyper-translocation of YopD 
and YopB 
We have demonstrated that Yersinia infection activates both the non-canonical and canonical 
inflammasomes (Fig. 4-1, Casson et al., 2013). Both the canonical and non-canonical 
inflammasome can potentially be activated downstream of the same virulence activity. 
Alternatively, multiple mechanisms could account for activation of the different inflammasomes, 
as well as activation of a single inflammasome. One model based on our data suggests that 
hyper-translocation of YopD mediates activation of both the non-canonical and canonical 
inflammasome through disruption of the lysosomal membrane (Fig. 6-2). We have shown that 
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YopD can colocalize with the lysosome (Fig. 4-2) and that Gbp2 is recruited to the lysosomes of 
Yersinia-infected cells, providing an indicator of lysosomal damage (Fig. 4-5). Notably, lysosomal 
disruption itself is a sufficient signal to activate the canonical NLRP3 inflammasome (Hornung et 
al., 2008). Potentially, the extent of host lysosomal content release modulates how much 
canonical inflammasome activation occurs. Damaged lysosomes that contain bacteria or bacterial 
PAMPs could also release bacterial products such as LPS. Currently, intracellular LPS is the only 
known non-canonical inflammasome activator (Hagar et al., 2013; Kayagaki et al., 2012; Shi et 
al., 2014). Yersinia pseudotuberculosis grown at 37 °C expresses a mix of tetra-acylated and 
penta-acylated LPS (Rebeil et al., 2004). Tetra-acylated LPS has been demonstrated to be non-
stimulatory or antagonistic to the non-canonical inflammasome (Hagar et al., 2013; Kayagaki et 
al., 2013). However, transfection of penta-acylated LPS from Francisella novicida activated the 
non-canonical inflammasome (Hagar et al., 2013). In previous work with TLR4, LPS from Yersinia 
pseudotuberculosis that was grown at 37 °C was significantly less stimulatory than LPS from 
Yptb grown at 21 °C. However, it did allow for some stimulation as measured by cytokine 
production (Rebeil et al., 2004). As recognition of intracellular LPS has generally followed the 
same trend as TLR4 recognition of LPS, the release of LPS from the lysosome may be activating 
the non-canonical inflammasome.  
 
Several experiments are still needed to test this model. To test whether canonical inflammasome 
activation is occurring by release of host lysosomal contents and not intracellular LPS alone, 
Casp11-/- macrophages would be pretreated with cathepsin B inhibitor or vehicle control, and then 
infected with Yersinia. Release of cathepsin B from the lysosome has previously been shown to 
be important for inflammasome activation downstream of lysosomal degradation (Hornung et al., 
2008). Therefore, inhibition of cathepsin B should decrease canonical inflammasome activation if 
degradation of the lysosome by YopD/B is the trigger for canonical inflammasome activation. In 
the case of the non-canonical inflammasome, we need to test whether LPS is the signal. We are 
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currently trying two methods to test this portion of the model. First, we will express YopD and 
YopB in the gram-positive bacterium Listeria monocytogenes to see if we can deliver YopD and 
YopB internally in the absence of LPS. By fusing the signal sequence of actA from Listeria to the 
N-terminus of yopD and yopB and expressing the genes downstream of the actA promoter, YopD 
and YopB will only be expressed when Listeria is inside a host cell and should be exported out of 
the Listeria due to the ActA signal sequence. If Listeria can tolerate expressing YopD and YopB, 
this experiment will potentially determine whether YopD and YopB are sufficient to activate the 
non-canonical inflammasome in the absence of LPS. However, this experiment cannot exclude 
the possibility that LPS is also activating the inflammasome. To test whether LPS is activating the 
non-canonical inflammasome during in vitro Yersinia infection, we will grow Yersinia pestis at 37 
°C overnight and for all three hours of the inducing culture. Using this method of growth will 
generate only tetra-acylated LPS and prevent any residual hexa-acylated LPS from the overnight 
or 1 hour of inducing culture growth at 26 °C from contaminating the infection. If the 37 °C grown 
Yersinia pestis fail to activate the non-canonical inflammasome, it suggests that LPS released 
from the lysosome is the signal during both Yersinia pestis and Yersinia pseudotuberculosis 
infection.  
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Figure 6-2: Model 1 – Release of lysosomal contents by YopD/B activates the canonical 
and non-canonical inflammasomes. Yersinia hyper-translocate YopD/B (burgundy) into the cell 
from either the plasma membrane or the lysosome. YopD/B associate with the membranes of 
both Yersinia containing and Yersinia free lysosome. This association causes damage and 
recruits Gbps (blue). Damage to the lysosomes allow for the release of both host and bacterial 
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products including LPS (black). Release of host proteins triggers NLRP3 canonical 
inflammasome activation while release of LPS leads to activation of the non-canonical caspase-
11 inflammasome. 
 
An alternative model for the activation of the non-canonical inflammasome is direct activation by 
YopD or YopB (Fig. 6-3). SipB, the Salmonella homolog of YopB, has previously been 
demonstrated to bind to the proform of caspase-1 (Hersh et al., 1999). As caspase-11 is the 
result of a gene duplication of caspase-1 (Sakamaki and Satou, 2009), YopB and potentially 
YopD may bind to caspase-11. If the Listeria experiment proposed above demonstrates that 
YopB and YopD delivery are sufficient for non-canonical inflammasome activation, 
immunoprecipitation of YopD and YopB will also be performed to test whether the activation 
occurs through direct binding. If YopD and YopB are sufficient to activate the non-canonical 
inflammasome either directly or indirectly, it would present new possibilities for how the non-
canonical inflammasome interacts with the host cell environment. As caspase-1 can be activated 
through multiple NLR proteins as well as through a caspase-8 mediated pathway (Lamkanfi and 
Dixit, 2009; Philip et al., 2014; Weng et al., 2014), it is conceivable that caspase-11 is activated 
by more than just the direct binding of LPS. 
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Figure 6-3: Model 2 - YopD/B activate caspase-11 non-canonical inflammasome. Yersinia 
hyper-translocate YopD/B (burgundy) into the cell from either the plasma membrane or the 
lysosome. YopD/B recruit Gbps (blue). YopD/B then activate the non-canonical inflammasome 
either by binding to capase-11 or to a currently unknown sensor. 
 
While lysosomal damage may result in canonical inflammasome activation, lysosomal damage is 
not the only possible stimulus for canonical inflammasome activation in response to hyper-
translocation of YopD and YopB. It is possible that hyper-translocation of YopD/B activates the 
canonical inflammasome by multiple mechanisms including lysosomal damage (Fig. 6-4A). 
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Alternatively, hyper-translocation of YopD/B may activate the canonical inflammasome through a 
lysosome-independent mechanism (Fig 6-4B). As YopD and YopB are translocated into the host 
cell and there are other internal membranes beside lysosomes, YopD and YopB may insert into 
these other membranes. Preliminary data suggest that in addition to being recruited to lysosomal 
membranes, YopD can also colocalize with the mitochondrial membrane (data not shown). 
Mitochondrial dysfunction and ROS production are important activators of the NLPR3 
inflammasome (Shimada et al., 2012; Zhou et al., 2011). In addition to the previously described 
cathepsin B inhibitor experiments to determine the contribution of lysosomal degradation to 
inflammasome activation, experiments are required to confirm if YopD and YopB actually 
colocalize with the mitochondria. Colocalization of YopD and YopB with mitochondria could cause 
increased production of mitochondrial ROS. Mitochondrial ROS has been demonstrated to 
participate in the activation of the NLRP3 inflammasome in response to various stimuli (Shimada 
et al., 2012; Zhou et al., 2011). One way to test if mitochondrial ROS is necessary for 
inflammasome activation in response to hyper-translocation of YopD/B is to over-express 
enzymes that break down ROS. Catalase converts the reactive oxygen species hydrogen 
peroxide into water and oxygen. A transgenic mouse strain called MCAT overexpresses human 
catalase and targets the enzyme to the mitochondria (Schriner et al., 2005). To test if YopD/B 
colocalization with mitochondria triggers inflammasome activation through increased 
mitochondrial ROS production, we will infect MCAT BMDMS with Yersinia. If mitochondrial 
hydrogen peroxide production is required for inflammasome activation, MCAT BMDMs should 
have decreased inflammasome activation as the catalase would quickly convert any hydrogen 
peroxide produced to water and oxygen. Alternatively, if a different species of reactive oxygen is 
required such as superoxide, we would not see a defect. Furthermore, as the non-canonical 
inflammasome is the dominant inflammasome, changes may be hard to see in the MCAT 
BMDMs. siRNA silencing of caspase-11 in MCAT BMDMs may be needed to see an effect. 
Additionally, colocalization of YopD or YopB with mitochondria could cause the release of 
cardiolipin from the mitochondria and activate the inflammasome in a ROS-independent manner 
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(Iyer et al., 2013). We will test for a role of cardiolipin in inflammasome activation by knocking 
down cardiolipin synthase and then infecting the macrophages. Understanding which 
mechanisms would recognize Yersinia infection in the absence of bacterial immune evasion 
provides insight into the key features of virulence for innate immune recognition.  Additionally, 
knowing the steps in the activation of the inflammasome reveals the potential points in the 
process of immune recognition that must either be inhibited or evaded by the bacteria. In the case 
of Yersinia, determining the mechanism by which the inflammasome should be activated 
suggests models for how YopK as well as YopJ in the context of YopM prevent inflammasome 
activation.    
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Figure 6-4: Model 3 - Multiple mechanisms for canonical inflammasome activation by 
Yersinia.  
A. Yersinia hyper-translocate YopD/B (burgundy) into the cell. YopD/B translocated into the cell 
associate with lysosomal and mitochondrial membranes.  Damage to the lysosomes allow for the 
release of host products. Release of host proteins triggers canonical NLRP3 inflammasome 
activation.  Insertion of YopD/B into mitochondrial membranes leads to ROS production and 
activation of canonical NLRP3 inflammasome. B. Yersinia hyper-translocate YopD/B (burgundy) 
into the cell. YopD/B translocated into the cell associate with lysosomal and mitochondrial 
membranes. Release of bacterial products from the lysosome activates the non-canonical 
inflammasome while ROS production as a result of YopD/B‘s insertion into the mitochondria 
results in NLRP3 canonical inflammasome activation.  
 
D. YopK evasion of the inflammasome  
Yersinia lacking all of the known effectors had been demonstrated to activate the inflammasome 
in vitro. Bacterial burdens of the effectorless strain were lower than wild-type due to caspase-
1/11-dependent mechanisms (Brodsky et al., 2010). This observation suggests that Yersinia 
encodes effectors that target the inflammasome pathways in order to allow Yersinia to utilize its 
T3SS without being detected and cleared by the host cell. Several Yops have since been 
identified to inhibit inflammasome activation during Yersinia infection. YopM has been identified to 
inhibit caspase-1 by either directly binding to caspase-1 or by recruiting the scaffolding protein IQ 
motif- containing GTPase-activating protein 1 (IQGAP1) (LaRock and Cookson, 2012; Chung et 
al., 2014). There is also the potential that interactions between YopM and the protein kinase 
RSK1 may be important for inhibition of inflammasome activation (Chung et al., 2014). Recently, 
YopJ has been shown to have a small role in inflammasome inhibition in primed macrophages 
although the mechanism is unclear (Schoberle et al., 2016). YopK was the first effector 
demonstrated to inhibit inflammasome activation (Brodsky et al., 2010). Deletion of YopK results 
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in significant caspase-1/11-dependent attenuation of infection in vivo. While YopK was the first 
Yersinia effector identified to inhibit inflammasome activation, the mechanism has been unclear. 
While the T3SS is well conserved among many gram-negative bacteria, YopK has no sequence 
homolog. Determining the mechanism by which YopK prevents inflammasome activation can 
potentially identify the presence or absence of functional homologs in other T3SS expressing 
bacteria. If no functional homologs exist, it would suggest that these bacteria evolved other 
changes that prevent recognition of the hyper-translocation of their translocon pore proteins. 
 
In addition to preventing inflammasome activation, YopK functions to decrease the size of the 
translocon pore and to negatively regulate translocation (Holmstrom et al., 1997). Our data 
suggests a model where YopK prevents activation of the inflammasome by limiting the 
translocation of YopD and YopB into the cell. Thorslund and colleagues (2011) previously 
performed a yeast two-hybrid screen to determine if YopK function required interaction with any 
host proteins. They determined that RACK1 interacted with WT YopK and that only YopK with the 
mutation TD45-46AA failed to interact with RACK1 in the yeast two-hybrid screen. They further 
showed that expression of YopKTD45-46AA allowed for increased translocation compared to WT. We 
initially sought to test whether interaction between YopK and RACK1 is required to prevent 
inflammasome activation. We generated the original TD45-46AA mutation in YopK as well as two 
mutations that were determined to allow for interaction with RACK1 (SK28-29AA and LR43-
44AA). We observed that both YopKLR43-44AA and YopKTD45-46AA allow for increased translocation 
of the effectors (Fig. 5-1B). This finding suggests that RACK1 interaction with YopK does not 
control translocation. Interestingly, both of these mutations failed to prevent inflammasome 
activation (Fig. 5-1C-E) and were located in the same region of the protein (Fig. 5-1A). Dewoody 
and colleagues (2013) demonstrated that the change of the charged aspartic acid residue to an 
alanine that was responsible for the increased translocation of effectors by YopKTD45-46AA. Future 
work needs to examine whether this single amino acid change is also responsible for allowing 
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activation of the inflammasome. As the other mutation in the region that allows for increased 
translocation also changes a charged residue to an alanine (LR43-44AA), it would be beneficial to 
test whether it is mutation of the charged residue in YopKLR43-44AA that allows for both increased 
translocation and inflammasome activation. If changes to the charge residues in this region are 
responsible, it would suggest that this region is important for interactions with host or bacterial 
molecules that regulate translocation. Determining the regions of YopK that are important for this 
regulation could help identify the mechanism by which YopK controls translocation and therefore 
controls inhibition of the inflammasome. One way to determine if YopK actually prevents 
inflammasome activation by regulating translocation would be to enable Yersinia to limit YopB 
and YopD translocation in a YopK-deficient setting. While based on sound logic, current attempts 
have failed to complement the intended activity and instead elucidated just how interconnected 
and balanced the T3SS is.  
	  
E. The T3SS is tuned to deliver effector proteins that disrupt host signaling while 
limiting anti-pathogen innate responses by the target cell 
Without the T3SS and its effectors, the three human pathogenic species of Yersinia are unable to 
infect mammals (Gemski et al., 1980a, Gemski et al., 1980b; Portnoy et al., 1981, Cornelis and 
Wolf-Watz, 1997). Like all bacteria that express T3SS, the effectors encoded by Yersinia play 
important roles in allowing the bacteria to invade, survive, and replicate in their chosen niche. 
Although essential to establishing a productive infection, the process of translocation must be 
highly regulated to avoid accidentally triggering innate immune pathways. One such example is 
the difference between YopJ and YopP, the Yersinia enterocolitica homolog of YopJ. While the 
two proteins are ninety-four percent identical, expression of YopP leads to higher cell death in 
vitro (Brodsky and Medzhitov, 2008). Interestingly, expressing YopP in Yersinia 
pseudotuberculosis during in vivo infection leads to an attenuated infection. The sequence 
difference in YopP allows for the protein to be translocated at a higher level resulting in an 
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increased inhibition of the NFκB and MAPK pathways (Brodsky and Medzhitov, 2008). While 
YopJ is thought to be important for penetrating the gut epithelial barrier during infection (Monack 
et al., 1998), the level of YopJ translocation must be tightly regulated to prevent triggering 
immune responses that can effectively clear the pathogen (Brodsky and Medzhitov, 2008). As 
described in our work, disregulated translocation and consequent hyper-translocation of YopD 
and YopB into the host cell leads to inflammasome activation (Fig. 3-3 – Fig. 3-7), which 
contributes to control of Yersinia infection (Brodsky et al., 2010; Zwack et al., 2015). Precise 
delivery of effectors and stringent control of T3SS components are required for effective function 
of the T3SS. Additionally, both effectors and structural components interact with each other to 
provide regulation (Holmstrom et al., 1997; Mejia et al., 2008; Williams and Straley, 1998). 
Therefore, modifications used to test one component of the system have the potential to 
detrimentally affect control of other components.  
 
The balance required for appropriate function of the T3SS can thus make it difficult to dissect the 
true function of components that regulate T3SS activity. The nature of the T3SS became clear 
when we attempted to test the hypothesis that YopK prevents inflammasome activation by 
negatively regulating translocation of YopD and YopB into the host cell. As LcrHmut1 allowed for 
translocation of effector Yops at normal levels but not YopD or YopB when expressed in a 
ΔyopEJK Yptb strain (Fig. 3-5), we proposed that expression of LcrHmut1 in a ΔyopK strain would 
complement YopK’s ability to prevent inflammasome activation and restore virulence. 
Interestingly, B6 mice completely cleared both WT and ΔyopK strains that expressed LcrHmut1 
after i.p. infection (Fig. 5-2 and data not shown). Additionally, translocation of YopE, YopM, and 
YopJ was significantly decreased in WT-lcrHmut1 strains in comparison to WT while ΔyopEJK 
and ΔyopEJK-lcrHmut1 strains had similar levels of translocation (Fig. 5-3). Furthermore, ΔyopK-
lcrHmut1 allowed for translocation of YopM and YopJ at equivalent levels to ΔyopK, but failed to 
translocate YopE at normal levels (Fig. 5-3). The only difference between ΔyopK-lcrHmut1 and 
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ΔyopEJK-lcrHmut1 is the presence of YopE and YopJ. YopE is a GTPase-activating protein 
(GAP) that downregulates Rho, Rac, and Cdc42 activity (Von Pawel-Rammingen et al., 2000). 
Translocation by the Yersinia T3SS has been shown to require activation of Rho downstream of 
Yersinia binding to β1 integrins (Mejia et al., 2008). Furthermore, YopE has previously been 
demonstrated to contribute to negatively regulate Yop delivery possibly by affecting actin 
structure at the membrane near the translocon pore (Mejia et al., 2008). This effect could result in 
a conformational change such as decreased pore size in the already altered translocon complex. 
Interestingly, YopE is smaller in size than both YopM and YopJ; thus, the decreased translocation 
is not caused by YopE being too large to fit through the pore. Instead, our findings indicate that a 
conformational shape change that exposes or hides different epitopes in the translocon is likely 
responsible for drastically reduced YopE translocation. Additionally, these findings may indicate 
an order to Yop effector secretion. If YopE is unable to exit the T3SS through the translocon, 
YopE would most likely block the T3SS and prevent translocation of other Yops. However, YopJ 
and YopM are translocated at normal levels in the YopK-deficient LcrHmut1 expressing strain. 
This finding could suggest that YopJ and YopM are translocated first. Alternatively, YopJ and 
YopM may be translocated normally as enough T3SSs are expressed that not every structure 
would be blocked by YopE. Thus, YopJ and YopM could be translocated through T3SSs that 
were not blocked by YopE. Furthermore, these findings imply that Yops have different 
sensitivities to changes in the T3SS structure (Fig. 6-5). These complex relationships between 
the T3SS, its effectors, and host cell processes should make changes to the T3SS difficult for 
bacteria. Understanding these relationships could present targets to render the T3SS ineffective 
and allow for natural clearance of the bacteria by the host.  
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Figure 6-5: Schematic of T3SS translocon and effector interactions. A. WT Yersinia allows 
for sufficient translocation of effector Yops to modulate host cell processes while limiting 
translocation of the translocon pore proteins. B. YopK-deficient Yersinia allows for increased 
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translocation of Yops including the pore proteins YopD and YopB. The increased translocation of 
YopD and YopB leads to inflammasome activation. C. WT Yersinia expressing LcrHmut1 
translocate smaller quantities of Yops. Mutations in LcrH, the chaperone protein of YopB and 
YopD, result in smaller translocons. In combination with YopK expression, the translocon pore 
may be too small to allow for efficient translocation. D. YopK-deficient Yersinia expressing 
LcrHmut1 translocate YopJ and YopM at normal levels but demonstrate significantly decreased 
YopE translocation. As YopE is smaller than both YopJ and YopM, the decrease in YopE 
translocation is most likely not a result of pore size. Expression of LcrHmut1 may result in a 
conformational change of the pore that affects a subset of Yops including YopE.  
F. A role for alternative therapies in the treatment of bacterial pathogens 
 With first the discovery of penicillin and then more antibiotics, our ability to combat previously 
lethal and debilitating bacterial infections increased dramatically. Most of our current antibiotics 
come from the environment where one microbial organism produces an antibiotic to kill another 
microbe either to protect its niche or itself (Davies and Davies, 2010). The same organisms often 
also need to protect from self-intoxication with the antibiotic; therefore, antibiotic resistance 
normally already exists in the environment (Davies, 1994). Additionally, it has been suggested 
that certain antibiotic resistance genes originally evolved to play physiological roles separate from 
antibiotic resistance (Alonso et al., 2001). Often times these antibiotic resistance genes are 
encoded on mobile genetic elements such as plasmids and thus can be transferred to other 
microbes under the correct circumstances (Davies, 1994; Martinez and Baquero, 2002). Antibiotic 
resistance is becoming more of a clinical issue. While most antibiotic resistant bacteria are still 
susceptible to some antibiotics, multi-drug resistance has emerged in a small number of bacteria 
that often cause nosocomial infections. One group often referred to as the ESKAPE bugs consist 
of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumanni, Pseudomonas aeruginosa, and Enterobacter species (Rice, 2008). Alternative 
therapies to our current antibiotics are needed to combat these infections. By understanding the 
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pathways that could clear the bacteria, the pathways that bacteria activate to increase 
pathogenesis, and the mechanics of virulence structures and factors required for survival of the 
bacteria, we can develop strategies to clear bacteria with the help of the immune system instead 
of directly killing the bacteria. Identifying pathways such as the inflammasome that would clear 
the pathogen in the absence of pathogen immune evasion provides targets for therapeutic 
intervention. Either by inactivating the pathogen’s mechanism of evasion or activating a parallel 
pathway that will generate the same downstream consequences, we could potentially promote 
pathogen clearance by the immune system. Finally, we need to find ways to counteract virulence 
structures, factors, and activities that are essential for productive infection. The T3SS is 
conserved among many bacteria. In fact, the T3SS of Yersinia and Pseudomonas aeruginosa 
(one of the ESKAPE bugs) are extremely similar. Inhibitors of Yersinia’s T3SS have been found 
to also inhibit the T3SS of other bacteria (Bailey et al., 2007; Harmon et al., 2010). Through 
defining the necessary interactions of the T3SS in a model bacterium, we can potentially design 
therapies that are effective for multiple bacterial infections. Employing multiple strategies to 
enhance clearance of the bacteria by the immune system can provide alternatives to classical 
antibiotics. 
 
G. Concluding Remarks 
The work performed in this dissertation elucidated both mechanisms by which the host 
recognizes the presence of Yersinia’s T3SS and the potential mechanism by which the Yersinia 
effector YopK prevents inflammasome activation. The mechanics of recognizing internal delivery 
of pore proteins are potentially broadly applicable among both gram-negative and gram-positive 
bacteria as well as other pathogens. Additionally, we have revealed further connections between 
the Yersinia effectors and T3SS function. Although effectors differ among bacterial species, there 
may be certain general rules and interactions required for T3SS function that can be found by 
understanding the rules and interactions needed for the Yersinia T3SS to function. The effort and 
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energy expended by bacterial pathogens to subvert immune responses demonstrate the 
importance and efficacy of these responses to control pathogens. Work to understand both the 
host mechanism that is being subverted and the pathogen mechanism of subverting the host 
response plays a vital role in defining the pathogenesis of infection. Only by understanding 
pathogenesis can we develop effective treatments.   
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